Skip Navigation

Advertise|Press|Contact|FAQ|CWConnect

Bookmark/Print/Share

Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Pulmonary/Respiratory Diseases | Family Medicine

Asthma Clinical Trials


A listing of Asthma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

Alabama

Mobile : Research Site

HZA 853/855 Asthma Studies for Children

View More »

Birmingham :

A Non-drug Study Profiling Asthma

Birmingham : University of Alabama at Birmingham Lung Health Center

Bronchial Thermoplasty in Severe Persistent Asthma

Birmingham :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Birmingham : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Birmingham : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Homewood : Teva Investigational Site 10165

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Mobile : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Oxford :

A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)

Ozark : Call for Information (Investigational Site 0047)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Pell City :

A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)

Alaska

Anchorage : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Arizona

Phoenix : Research Site

A clinical research study for asthmatics 12 years and over.

Phoenix : Arizona Research Center

Asthma

Scottsdale : Research Site

A clinical research study for asthmatics 12 years and over.

View More »

Glendale : Call for Information (Investigational Site 9038)

Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)

Mesa : Call for Information (Investigational Site 0045)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Phoenix : Call for Information (Investigational Site 0055)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Phoenix : Phoenix Children's Hospital

A Pilot Study Involving an Asthma Management Program for Inner-city Early Head Start Children

Scottsdale : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Scottsdale : Teva Investigational Site 10104

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Scottsdale : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Tucson : University of Arizona

Diagnosis of Exercise-Induced Bronchospasm (EIB) and Asthma in National Collegiate Athletic Association (NCAA) Division I Athletes

Tucson : University of Arizona, Arizona Respiratory Center

Long-acting Beta Agonist Step Down Study

Arkansas

Little Rock : Research Site

A clinical research study for asthmatics 12 years and over.

Little Rock : Research Site

HZA 853/855 Asthma Studies for Children

View More »

Fort Smith : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Little Rock : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Little Rock : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Little Rock : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

California

Bell : Research Site

A clinical research study for asthmatics 12 years and over.

Canoga Park : Research Site

A clinical research study for asthmatics 12 years and over.

Costa Mesa : WCCT Global

Asthma Research Study

Costa Mesa : WCCT Global

Asthma Research Study

Encinitas : Research Site

A clinical research study for asthmatics 12 years and over.

Fountain Valley : Research Site

A clinical research study for asthmatics 12 years and over.

Fresno : Research Site

A clinical research study for asthmatics 12 years and over.

Huntington Park : Rx for Life, Inc.

Are you African-American? Do you have Asthma?

Long Beach : Novo Research, Inc.

Adolescent and Adult Subjects with Asthma

Long Beach : Research Site

HZA 853/855 Asthma Studies for Children

Los Angelas : Research Site

A clinical research study for asthmatics 12 years and over.

Los Angeles : Research Site

A clinical research study for asthmatics 12 years and over.

Mission Viejo : Research Site

A clinical research study for asthmatics 12 years and over.

Mission Viejo : Research Site

HZA 853/855 Asthma Studies for Children

Newport Beach : Research Site

HZA 853/855 Asthma Studies for Children

Orange : Research Site

A clinical research study for asthmatics 12 years and over.

Redwood City : Research Site

A clinical research study for asthmatics 12 years and over.

Rolling Hills Estates : Peninsula Research Associates, Inc.

Asthma - Ages 18 to 70, Up to $810 in compensation

Rolling Hills Estates : Research Site

HZA 853/855 Asthma Studies for Children

San Gabriel : California Center for Clinical Research

A study evaluating inhalers for the treatment of Asthma in Adolescents and Adults.

San Jose : Research Site

A clinical research study for asthmatics 12 years and over.

Torrance : Research Site

A clinical research study for asthmatics 12 years and over.

Torrance : Research Site

A clinical research study for asthmatics 12 years and over.

Walnut Creek : Research Site

A clinical research study for asthmatics 12 years and over.

Westlake Village : Research Site

A clinical research study for asthmatics 12 years and over.

Wildomar : Research Site

A clinical research study for asthmatics 12 years and over.

View More »

Bakersfield :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Bakersfield : Teva Investigational Site 10573

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Bakersfield : Teva Investigational Site 10173

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Buena Park : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Costa Mesa : Teva Investigational Site 10163

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Cypress : West Coast Clinical Trials, LLC

Assessment and Evaluation of Pharmacokinetic Profile of E004 in Healthy Adults

Cypress : West Coast Clinical Trials Global

Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma

Cypress : Research Site

Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects

Encinitas : Teva Investigational Site 10156

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Encinitas : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Encinitas : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Folsom : Site 1

WheezoMeter® Correlation Study

Fountain Valley : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Fountain Valley :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Fountain Valley : Call for Information (Investigational Site 0124) Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Fountain Valley : Teva Investigational Site 10590

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Fresno : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Fresno : Research Center of Fresno

Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease

Fullerton : Call for Information (Investigational Site 0064)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Fullerton : California Research Medical Group, Inc

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Fullerton :

A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)

Fullerton :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Fullerton : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Glendale : Research Site

Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects

Granada Hills : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Granada Hills : Teva Investigational Site 10551

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Granada Hills : Teva Investigational Site 10151

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Granada Hills :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Huntington Beach : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Huntington Beach : Allergy & Asthma Specialists Medical Group

A Study of ARRY-502 in Patients With Persistent Asthma

Huntington Beach : Teva Investigational Site 10157

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Huntington Beach : Teva Investigational Site 10176

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Huntington Beach : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Huntington Beach : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Huntington Beach : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Long Beach : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Long Beach : Teva Investigational Site 10147

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Long Beach : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Long Beach : Health Care Partners Medical Group

Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease

Long Beach : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Long Beach : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Long Beach : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Los Angeles : GSK Investigational Site

6-month Safety and Benefit Study of ADVAIR in Children 4-11 Years Old

Los Angeles : California Allergy & Asthma Medical Group, INC

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Los Angeles : Allergy Medical Clinic Research Division

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Los Angeles : Southern California Institute for Respiratory Diseases, Inc.

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Los Angeles : Allergy Medical Clinic - Research Division

A Study of ARRY-502 in Patients With Persistent Asthma

Los Angeles : California Allergy & Asthma Med. Group

A Study of ARRY-502 in Patients With Persistent Asthma

Los Angeles : Southern California Institute for Respiratory Diseases Inc

A Study of ARRY-502 in Patients With Persistent Asthma

Los Angeles : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Los Angeles : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Los Angeles : Vectura Clinical Trial Site 01001

Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma

Los Angeles : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Los Angeles :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Los Angeles : Investigational Site

Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing

Los Angeles : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Mission Viejo : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Mission Viejo : Allergy & Asthma Associates of Southern California

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Mission Viejo : Southern California Research

A Study of ARRY-502 in Patients With Persistent Asthma

Mission Viejo :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Mission Viejo : Call for Information (Investigational Site 0105) Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Mission Viejo : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Newport Beach : Teva Investigational Site 10536

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Newport Beach : Teva Investigational Site 10136

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Newport Beach : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Newport Beach : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Newport Beach : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Orange : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Orange : CHOC PSF, AMC, Division of Allergy, Asthma & Immunology

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Orange :

A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)

Orange :

A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)

Orange : Teva Investigational Site 10540

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Orange : Teva Investigational Site 10140

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Orange : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Orange : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Orange : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Palmdal : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Palmdale : Teva Investigational Site 10578

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Rancho Mirage : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Redwood City :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Redwood City : Teva Investigational Site 10185

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Riverside :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Riverside : Call for Information (Investigational Site 0125) Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Riverside : Teva Investigational Site 10143

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Riverside : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Riverside : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Riverside : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Riverside : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Rolling Hills Estates : Peninsula Research Associates

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Rolling Hills Estates : Peninsula Research Associates

A Study of ARRY-502 in Patients With Persistent Asthma

Rolling Hills Estates : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Rolling Hills Estates : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Rolling Hills Estates : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Roseville : Call for Information (Investigational Site 9043)

Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)

Sacramento : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Sacramento : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Sacramento : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Sacramento :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

San Diego : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

San Diego : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

San Diego : Allergy & Asthma Med Group/Research Center

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

San Diego : Allergy Associates Medical Group. Inc.

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

San Diego : Allergy Associates Medical Group

A Study of ARRY-502 in Patients With Persistent Asthma

San Diego : Teva Investigational Site 10182

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

San Diego : Teva Investigational Site 10130

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

San Diego : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

San Diego : University of Southern California, San Diego

Long-acting Beta Agonist Step Down Study

San Diego : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

San Francisco : Ovation Research Group

Impact of Asthma Treatments on Daily Activities

San Jose : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

San Jose : Call for Information (Investigational Site 0052)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

San Jose : Allergy & Asthma Associates of Santa Clara Valley

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

San Jose : Teva Investigational Site 10563

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

San Jose : Teva Investigational Site 10179

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

San Jose : Amphastar Site 1

Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation

San Jose : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

San Jose : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

San Jose :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

San Jose : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

San Mateo : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

San Mateo : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

South San Francisco : Genentech Trial Information Support Line

An Observational Study of the Use and Safety of Xolair During Pregnancy

Stockton : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Stockton : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Stockton : Bensch Research Associates

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Stockton : Call for Information (Investigational Site 0104) Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Stockton : Teva Investigational Site 10506

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Stockton : Teva Investigational Site 10106

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Stockton : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Stockton : 205.456.01004 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Torrance :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Vista : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Vista : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Walnut Creek : Teva Investigational Site 10529

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Walnut Creek : Teva Investigational Site 10129

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Walnut Creek : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Woodland : Woodland Medical Center

Effectiveness of the Asthmapolis Monitoring System

Colorado

Centennial : 1st International Clinical Research Center

Is your asthma uncontrolled?

Colorado MERCKngs : Research Site

A clinical research study for asthmatics 12 years and over.

Wheat Ridge : Research Site

A clinical research study for asthmatics 12 years and over.

Wheat Ridge : Western States Clinical Research, Inc.

Will you help us evaluate an investigational study medication for the treatment of moderate to severe Asthma?

View More »

Centennial : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Centennial : Colorado Allergy and Asthma Clinic, PC

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Centennial : Colorado Allergy and Asthma Center

A Study of ARRY-502 in Patients With Persistent Asthma

Centennial : IMMUNOe International Research Centers

A Study of ARRY-502 in Patients With Persistent Asthma

Centennial :

A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)

Centennial :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Centennial : Teva Investigational Site 10545

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Centennial : Teva Investigational Site 10145

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Colorado Springs : Asthma & Allergy Associates, PC

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Colorado Springs : Asthma & Allergy Associates PC

A Study of ARRY-502 in Patients With Persistent Asthma

Colorado Springs : Teva Investigational Site 10572

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Colorado Springs : Teva Investigational Site 10172

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Colorado Springs : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Colorado Springs :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Denver : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Denver : Colorado Allergy & Asthma Centers, PC

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Denver : National Jewish Health

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Denver : Teva Investigational Site 10133

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Denver : Teva Investigational Site 10154

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Denver : National Jewish Medical and Research Center

Cell Biology of Steroid Resistant Asthma

Denver : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Denver : Teva Investigational Site 10453

Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects

Denver :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Denver : 205.446.01011 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Denver : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Denver : National Jewish Health

Identification of Molecular Biomarkers to Stratify Patients With Refractory Asthma

Denver : National Jewish Health

Markers of Airway Inflammation in BAL Fluid From Children With Asthma

Denver : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Denver : Research Site

Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects

Denver : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Engelwood : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Englewood : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Lakewood : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Thornton : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Wheat Ridge : Rocky Mountain Center for Clinical Research

A Study of ARRY-502 in Patients With Persistent Asthma

Wheat Ridge : Teva Investigational Site 10128

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Wheat Ridge : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Wheat Ridge : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Connecticut

New Haven :

A Non-drug Study Profiling Asthma

New Haven : Yale University Center for Asthma and Airway Disease

Bronchial Thermoplasty in Severe Persistent Asthma

Waterbury : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Waterbury : Teva Investigational Site 10528

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Waterbury :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Florida

Aventura : Florida Center for Allergy and Asthma Research

12 week dose ranging study to evaluate the efficacy and safety of Fluticasone Propionate Spiromax administered twice daily compared with placebo in adolescents and adults with persistent asthma uncontrolled on non-steroidal therapy

Aventura : Research Site

A clinical research study for asthmatics 12 years and over.

Aventura : Research Site

HZA 853/855 Asthma Studies for Children

Bradenton : Research Site

A clinical research study for asthmatics 12 years and over.

Cocoa : Research Site

HZA 853/855 Asthma Studies for Children

Coral Gables : Research Site

A clinical research study for asthmatics 12 years and over.

Hialeah : Research Site

A clinical research study for asthmatics 12 years and over.

Kissimmee : Research Site

A clinical research study for asthmatics 12 years and over.

Miami : Florida Center for Allergy and Asthma Research

12 week dose ranging study to evaluate the efficacy and safety of Fluticasone Propionate Spiromax administered twice daily compared with placebo in adolescents and adults with persistent asthma uncontrolled on non-steroidal therapy

Miami : Research Site

A clinical research study for asthmatics 12 years and over.

Miami : Research Site

A clinical research study for asthmatics 12 years and over.

Miami : Research Site

A clinical research study for asthmatics 12 years and over.

Miami : Research Site

A clinical research study for asthmatics 12 years and over.

Miami : Research Site

HZA 853/855 Asthma Studies for Children

Ocala : Research Site

A clinical research study for asthmatics 12 years and over.

Ormond Beach : Peninsula Research, Inc. Updated

Do you suffer from asthma?

Panama City : Emerald Coast Research Associates

Research study for Asthma

Pinellas Park : Radiant Research - St. Petersburg

Clinical Research for Asthma

Pinellas Park : Radiant Research - St. Petersburg

Clinical Research Study for Asthma

Sarasota : Research Site

A clinical research study for asthmatics 12 years and over.

St. Petersburg : SCORE Physician Alliance

Do you, or does your child have asthma?

Tampa : Clinical Research of West Florida, Inc.

Do you have trouble controlling your asthma?

West Palm Beach : Palm Beach Research Center

Have you been diagnosed with Asthma that is sometimes difficult to control?

Winter Park : Research Site

A clinical research study for asthmatics 12 years and over.

View More »

Altamonte Springs : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Aventura : Florida Center for Allergy & Asthma Research

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Aventura : Novartis Investigative Site

A Study to Establish the Efficacy of QBX258 in Patients With Moderate to Severe Asthma

Aventura : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Aventura : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Boyton Beach : Teva Investigational Site 10556

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Clearwater : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Clearwater : Teva Investigational Site 11507

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Clearwater : Teva Investigational Site 11118

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Clearwater : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Clearwater : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Coral Gables : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Coral Gables : Call for Information (Investigational Site 0068)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Gainesville : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Gainesville :

A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)

Hialeah : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Jacksonville : Clinical Neuroscience Solutions

A Study of ARRY-502 in Patients With Persistent Asthma

Jacksonville : Nemours Children's Clinic

Genotype Stratified Pharmacokinetic Study of Montelukast

Jacksonville : Nemours Children's Clinic

Long-acting Beta Agonist Step Down Study

Jacksonville : Nemours Children's Clinic

Transporter Mediated Uptake of Montelukast

Kissimee : Teva Investigational Site 11525

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Kissimmee : Pulmonary Disease Specialists

A Study of ARRY-502 in Patients With Persistent Asthma

Lehigh Acres : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Melbourne : Accelovance

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Miami : Teva Investigational Site 10060

A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma

Miami : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Miami : Call for Information (Investigational Site 0044)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Miami : South Florida Research Trials

A Study of ARRY-502 in Patients With Persistent Asthma

Miami : Teva Investigational Site 10537

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Miami : Teva Investigational Site 11508

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Miami : Teva Investigational Site 11514

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Miami : Teva Investigational Site 11120

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Miami : Teva Investigational Site 10137

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Miami : Teva Investigational Site 10153

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Miami : Teva Investigational Site 11128

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Miami : Pulmonary Human Research Laboratory, University of Miami, Miller School of Medicine

Acute Airway Vascular Smooth Muscle Effects of Inhaled Budesonide

Miami : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Miami : Research Site

Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects

Miami : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

North Palm Beach :

A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)

Ocala : Teva Investigational Site 10571

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Ocala : Teva Investigational Site 10171

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Opalocka : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Orange City : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Orlando : GSK Investigational Site

SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.

Port Charlotte : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Sarasota : Sarasota Clinical Research

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Sarasota : Teva Investigational Site 10178

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Sarasota : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Sarasota : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

South Miami : Teva Investigational Site 10593

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

South Miami : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Tallahassee : Allergy & Asthma Diagnostic Treatment Center

A Study of ARRY-502 in Patients With Persistent Asthma

Tallahassee : Teva Investigational Site 10161

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Tallahassee : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Tampa : Call for Information (Investigational Site 0059)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Tampa : Teva Investigational Site 10139

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Tampa : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Tampa : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Valrico : Investigational Site

Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing

Winter Park : Florida Pulmonary Research Institute

A Study of ARRY-502 in Patients With Persistent Asthma

Winter Park :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Georgia

Atlanta : Research Site

A clinical research study for asthmatics 12 years and over.

Atlanta : Radiant Research - Atlanta

Clinical Research for Asthma

Atlanta : Pinnacle Trials, Inc.

Do you have both Diabetes & Asthma?

Columbus : Southeast Regional Research Group - Columbus

Flute Clinical Study - Asthma

Columbus : Southeast Regional Research Group - Columbus

Trumpet Clinical Study - Asthma

Gainesville : Research Site

A clinical research study for asthmatics 12 years and over.

Lawrenceville : DataQuest Medical Research, LLC

Adult Asthma Study for African American Patients

Savannah : Research Site

A clinical research study for asthmatics 12 years and over.

Savannah : Research Site

HZA 853/855 Asthma Studies for Children

Stockbridge : Clinical Research Atlanta

Do you, or does your child have asthma? The study is a clinical research study being conducted worldwide. The study is comparing a medication which is a combination of two differenct drugs (fluticasone propionate and salmeterol) to a medication that has only one drug (fluticasone propionate alone). Both the combination drug and fluticasone propionate alone are currently available by prescription outside this clinical research study.

View More »

Albany : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Albany : Georgia Pollens Clinical Research Centers, Inc.

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Albany :

A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)

Albany :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Albany : Teva Investigational Site 11504

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Albany : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Columbus : Brookstone Centre Parkway

A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma

Columbus : Teva Investigational Site 10511

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Columbus : Teva Investigational Site 10111

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Columbus : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Decatur :

A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)

Duluth :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Gainesville : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Gainesville : Teva Investigational Site 10180

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Gainsville : Call for Information (Investigational Site 0130) Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Lawrenceville : Teva Investigational Site 10168

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Lawrenceville :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Savannah : Call for Information (Investigational Site 0109) Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Savannah : Teva Investigational Site 11510

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Savannah : Teva Investigational Site 11124

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Savannah : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Savannah : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Savannah :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Savannah : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Idaho

Eagle : Research Site

HZA 853/855 Asthma Studies for Children

Meridian : Research Site

A clinical research study for asthmatics 12 years and over.

Meridian : Advanced Clinical Research, ID

Do You Have Trouble Controlling Your Asthma?

Twin Falls : Research Site

A clinical research study for asthmatics 12 years and over.

View More »

Coeur D'Alene : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Couer D'Alene : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Eagle : Idaho Allergy DBA Idaho Research

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Eagle : Idaho Research

A Study of ARRY-502 in Patients With Persistent Asthma

Meridian : Teva Investigational Site 10116

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Twin Falls :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Illinois

Chicago : Research Site

A clinical research study for asthmatics 12 years and over.

Decatur : Research Site

A clinical research study for asthmatics 12 years and over.

DeKalb : Research Site

A clinical research study for asthmatics 12 years and over.

River Forest : Asthma and Allergy Center of Chicago, SC

Asthma Research for adult asthmatics using daily asthma medications (ICS)

River Forest : Asthma and Allergy Center of Chicago, SC

Research study for people with uncontrolled severe Asthma. If you are taking inhaled corticosteroids, need to use rescue several times a week and if you have been sick with asthma worsening more than two times during last year; you may be eligible to participate in our asthma study.

Shiloh : Research Site

HZA 853/855 Asthma Studies for Children

View More »

Chicago : University of Chicago

Bronchial Thermoplasty in Severe Persistent Asthma

Chicago : Cedar-Crosse Research Center

Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease

Chicago : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Hinsdale : Investigational Site

Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing

Normal : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Normal : Sneeze, Wheeze & Itch Associates

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Normal : Sneeze, Wheeze & Itch

A Study of ARRY-502 in Patients With Persistent Asthma

Normal :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Normal : Call for Information (Investigational Site 0123) Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Normal : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Normal : 205.456.01008 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Normal : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Normal : Call for Information (Investigational Site 9048)

Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)

River Forest : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

River Forest : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Shiloh : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Skokie : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Springfield : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Indiana

Evansville : Research Site

A clinical research study for asthmatics 12 years and over.

South Bend : Research Site

A clinical research study for asthmatics 12 years and over.

View More »

Anderson : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Evansville : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Evansville : Novartis Investigative Site

Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma

Evansville : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Indianapolis : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Michigan City : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

South Bend : Teva Investigational Site 10527

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

South Bend : Teva Investigational Site 10127

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Iowa

Iowa City : Research Site

A clinical research study for asthmatics 12 years and over.

View More »

Iowa City :

A Non-drug Study Profiling Asthma

Iowa City : University of Iowa

Bronchial Thermoplasty in Severe Persistent Asthma

Iowa City : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Kansas

Lenexa : Research Site

A clinical research study for asthmatics 12 years and over.

Lenexa : Research Site

HZA 853/855 Asthma Studies for Children

Overland Park : Radiant Research - Kansas City

Clinical Research for Asthma

Topeka : Research Site

A clinical research study for asthmatics 12 years and over.

View More »

Lenexa : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Overland Park : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Overland Park :

A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)

Overland Park :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Overland Park : Teva Investigational Site 11501

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Topeka : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Kentucky

Lexington : Central Kentucky Research Associates

Asthma

Lexington : University of Kentucky Chandler Medical Center

Asthma Volunteers Needed for Research Study

Nicholasville : Research Site

HZA 853/855 Asthma Studies for Children

Owensboro : Research Site

A clinical research study for asthmatics 12 years and over.

View More »

Lexington : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Lexington : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Louisville :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Nicholasville : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Owensboro : Teva Investigational Site 11130

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Owensboro : Novartis Investigative Site

Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma

Owensboro : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Louisiana

Sunset : Research Site

A clinical research study for asthmatics 12 years and over.

View More »

Marrero : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Metairie : Teva Investigational Site 10113

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Metairie : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Metairie : Call for Information (Investigational Site 9033)

Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)

Metarie : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

New Orleans : LSU Health Sciences

Bronchial Thermoplasty in Severe Persistent Asthma

Shreveport : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Sunset : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Maine

Bangor : Teva Investigational Site 10564

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Bangor : Teva Investigational Site 10164

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Bangor : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Bangor : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Maryland

Baltimore : Research Site

A clinical research study for asthmatics 12 years and over.

Salisbury : Research Site

A clinical research study for asthmatics 12 years and over.

White Marsh : Research Site

HZA 853/855 Asthma Studies for Children

View More »

Baltimore : Johns Hopkins Asthma and Allergy Center

A Comparison of Mometasone to Advair in Patients With Milder Persistent Asthma

Baltimore : Chesapeake Clinical Research, Inc.

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Baltimore : Chesapeake Clinical Research Inc

A Study of ARRY-502 in Patients With Persistent Asthma

Baltimore :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Baltimore : Johns Hopkins Asthma and Allergy Center

Effect of Anti-IgE in Non-Allergic Asthma

Baltimore : 205.456.01003 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Baltimore : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Bethesda : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Bethesda : NIH Clinical Center

A Safety Trial of DAS181 (Fludase®) in Adult Subjects With Well-Controlled Asthma or Bronchiectasis

Bethesda : Teva Investigational Site 10158

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Bethesda : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Bethesda : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Columbia : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Lanham : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Largo : Teva Investigational Site 10110

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Wheaton : Call for Information (Investigational Site 0072)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Wheaton : Teva Investigational Site 10577

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Wheaton : Teva Investigational Site 10177

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Wheaton : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

White Marsh : Call for Information (Investigational Site 0069)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

White Marsh : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Massachusetts

Brockton : Research Site

A clinical research study for asthmatics 12 years and over.

North Dartmouth : Research Site

A clinical research study for asthmatics 12 years and over.

View More »

Boston : St. Elizabeth's Medical Center

Bronchial Thermoplasty in Severe Persistent Asthma

Boston : Beth Israel Deaconess Medical Center

Bronchial Thermoplasty in Severe Persistent Asthma

Burlington : Lahey Clinic

Bronchial Thermoplasty in Severe Persistent Asthma

North Dartmouth : Northeast Medical Research Associates, Inc.

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

North Dartmouth : Northeast Medical Research Associates

A Study of ARRY-502 in Patients With Persistent Asthma

North Dartmouth : Teva Investigational Site 10546

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

North Dartmouth : Teva Investigational Site 10138

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

North Dartmouth : Teva Investigational Site 10146

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

North Dartmouth : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

North Dartmouth : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

North Dartmouth : Teva Investigational Site 10452

Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects

North Dartmouth : 205.446.01003 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

North Dartmouth : Teva Investigational Site 10236

Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma

North Dartmouth : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Michigan

Ann Arbor : ClinSite, LLC

Diagnosed with Asthma?

Minneapolis : Research Site

A clinical research study for asthmatics 12 years and over.

St Clair Shores : Research Site

A clinical research study for asthmatics 12 years and over.

View More »

Ann Arbor : University of Michigan

Role of Cysteinyl Leukotrienes in the Pathogenesis of Asthma in Obesity

Bay City : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Detroit : Henry Ford Hospital

Bronchial Thermoplasty in Severe Persistent Asthma

Grand Blanc : Grand Blanc Medical

A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma

Grand Rapids : Spectrum Health Hospitals

Bronchial Thermoplasty in Severe Persistent Asthma

Kalamazoo : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Southfield : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Troy : Teva Investigational Site 11502

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Ypsilanti : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Ypsilanti : Respiratory Medicine Researh Institute of Michigan

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Minnesota

Chaska : Ridgeview Research

Asthma

Minneapolis : Clinical Research Institute, MN

731/732 Asthma Research Study for Adolescents and Adults

Minneapolis : Clinical Research Institute, MN

738/739 Adult Asthma Research Study

Minneapolis : Clinical Research Institute, MN

Adult Asthma Research Study_707

Plymouth : Research Site

A clinical research study for asthmatics 12 years and over.

View More »

Duluth : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Edina : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Minneapolis : Clinical Research Institute

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Minneapolis : Clinical Research Institute

A Study of ARRY-502 in Patients With Persistent Asthma

Minneapolis : Teva Investigational Site 10131

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Minneapolis : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Minneapolis : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Minneapolis : Novartis Investigative Site

Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma

Minneapolis : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Plymouth : Clinical Research Institute, Inc.

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Plymouth : Clinical Research Institute

A Study of ARRY-502 in Patients With Persistent Asthma

Plymouth : Teva Investigational Site 10531

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Plymouth : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Rochester : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

St. Paul : HealthPartners Specialty Center, Lung and Sleep Health

Bronchial Thermoplasty in Severe Persistent Asthma

Mississippi

Vicksburg : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Missouri

Columbia : Research Site

HZA 853/855 Asthma Studies for Children

Creve Couer : The Clinical Research Center, LLC

Have you been using a maintenance inhaler to treat your asthma for the last 6 months? If so you may qualify for an asthma research study.

Rolla : Research Site

A clinical research study for asthmatics 12 years and over.

Rolla : Research Site

HZA 853/855 Asthma Studies for Children

St. Louis : Research Site

A clinical research study for asthmatics 12 years and over.

St. Louis : Research Site

A clinical research study for asthmatics 12 years and over.

St. Louis : Washington University in St. Louis - Center for Clinical Studies

A research study for severe asthma seeks participants.

St. Louis : Washington University in St. Louis - Center for Clinical Studies

A Washington University asthma study seeks volunteers 12 - 75 years of age.

St. Louis : Washington University in St. Louis - Center for Clinical Studies

A Washington University asthma study seeks volunteers that take Advair, Dulera or Symbicort for their asthma.

St. Louis : Washington University

Are you taking Xolair?

St. Louis : Midwest Clinical Research LLC

Asthma Clinical Trial

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Asthma patients! Do you use controller medications to treat your asthma?

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Asthma Study Seeks Volunteers!

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Attention Asthmatics! Washington University seeks asthmatics for a research study using an add-on treatment study medication.

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Attention Asthmatics! Washington University seeks participants for a research study on severe asthma.

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Attention Female Asthmatics! Washington University seeks female asthmatics for a research study looking at the effects of an asthma medication!

St. Louis : Radiant Research - St. Louis

Clinical Research Study for Asthma

St. Louis : The Clinical Research Center, LLC

Do you continue to experience asthma symptoms despite treatment with medication? We are seeking asthmatics who are currently on high-dose inhaled corticosteriods to participate in an clinical trial for asthma.

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Do you have a runny, stuffy nose or sinus infection or inflammation?

St. Louis : The Clinical Research Center, LLC

Do you have asthma and allergies have been treated with prednisone in the last 18 months? If so you may qualify for an asthma study.

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Do you have asthma?

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Do you have asthma? Are you interested in taking Vitamin D?

St. Louis : The Clinical Research Center, LLC

Do you use a rescue inhaler on a weekly basis to treat your asthma? If so you may qualify for an asthma research study.

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Do you use daily inhaled corticosteroids?

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Healthy Participants and Participants with severe asthma are needed for a research study at Washington University.

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Is Your Asthma Well Controlled? Are You Taking Dulera, Symbicort, or Advair for Your Asthma?

St. Louis : Washington University in St. Louis - Center for Clinical Studies

Participants with mild asthma are needed for a research study at Washington University.

View More »

Chesterfield : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Columbia : Clinical Research of The Ozarks, Inc.

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Columbia : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Columbia : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Columbia : 205.456.01007 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Columbia : 205.445.01002 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Columbia : 205.446.01009 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Columbia : 205.443.12003 Boehringer Ingelheim Investigational Site

Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

Kansas City : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Kansas City :

A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)

Kansas City : University of Missouri, Kansas City School of Medicine

Long-acting Beta Agonist Step Down Study

Kansas City : Investigational Site

Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing

Ozark : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Rolla : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Rolla : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Saint Louis :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

St Louis : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

St Louis : The Clinical Research Center, LLC

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

St Louis :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

St Louis : Teva Investigational Site 10589

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

St. Louis : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

St. Louis :

A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)

St. Louis : Teva Investigational Site 10575

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

St. Louis : Teva Investigational Site 10175

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

St. Louis : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

St. Louis : Washington University School of Medicine

Bronchial Thermoplasty in Severe Persistent Asthma

St. Louis : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

St. Louis : Teva Investigational Site 10455

Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects

St. Louis : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

St. Louis : Washington University/St. Louis University

Long-acting Beta Agonist Step Down Study

St. Louis : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Warrensburg : Call for Information (Investigational Site 0118) Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Warrensburg : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Warrensburg : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Montana

Billings : Research Site

A clinical research study for asthmatics 12 years and over.

Missoula : Research Site

A clinical research study for asthmatics 12 years and over.

Missoula : Montana Medical Research, Inc.

Have you been diagnosed with Asthma?

View More »

Billings : Billings Clinic Research Center

Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease

Boseman : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Bozeman : Clinical Research Group of Montana PLLC

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Bozeman : Clinical Research Group of Montana

A Study of ARRY-502 in Patients With Persistent Asthma

Nebraska

Bellevue : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Bellevue : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Bellevue : The Asthma & Allergy Center

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Bellevue : The Asthma & Allergy Center

A Study of ARRY-502 in Patients With Persistent Asthma

Bellevue :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

View More »

Bellevue : Teva Investigational Site 10518

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Bellevue : Teva Investigational Site 10118

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Bellevue : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Grand Island : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Omaha : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Omaha : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Omaha :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Omaha : Teva Investigational Site 10550

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Omaha : Teva Investigational Site 10150

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Omaha : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Omaha : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Papillion : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Nevada

Las Vegas : Research Site

A clinical research study for asthmatics 12 years and over.

View More »

Las Vegas :

A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)

Las Vegas : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Reno :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

New Jersey

Berlin : Research Site

A clinical research study for asthmatics 12 years and over.

Edison : Anderson & Collins Clinical Research, Inc.

Asthma Research Study

View More »

Berkely Heights : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Brick :

A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)

Brick : Teva Investigational Site 10114

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Brick : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Brick : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Cedar Knolls : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Cherry Hill : Teva Investigational Site 10559

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Cherry Hill : Teva Investigational Site 10193

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Edison :

A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)

Edison :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Hillsborough : Teva Investigational Site 10501

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Hillsborough : Teva Investigational Site 10101

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Ocean : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Ocean : Atlantic Research Center, LLC

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Princeton : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Skillman : Princeton Center for Clinical Research

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Skillman : Princeton Center for Clinical Research

A Study of ARRY-502 in Patients With Persistent Asthma

Skillman : Teva Investigational Site 10155

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Skillman : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Skillman : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Skillman : Teva Investigational Site 10454

Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects

Skillman : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Summit :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Teaneck : Call for Information (Investigational Site 9049)

Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)

Verona : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Verona : Allergy Consultants, PA

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Verona :

A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)

West Orange : Teva Investigational Site 10188

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

New Mexico

Albuquerque :

A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)

Albuquerque : Teva Investigational Site 11503

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Albuquerque : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

New York

Bronx : Biomedical Research Alliance of New York

Asthma

Bronx : Biomedical Research Alliance of New York

Asthma

Bronx : Biomedical Research Alliance of New York

Asthma

Brooklyn : Research Site

A clinical research study for asthmatics 12 years and over.

Corning : Research Site

HZA 853/855 Asthma Studies for Children

Mineola : Winthrop University Hospital Clinical Trials Center

Asthma Study - Are You Taking Xolair

New Hyde Park : Biomedical Research Alliance of New York, LLC

Symbicort treatment for patients with asthma

New York : Biomedical Research Alliance of New York, LLC

Symbicort treatment for patients with asthma

Newburgh : Research Site

A clinical research study for asthmatics 12 years and over.

North Syracuse : Research Site

A clinical research study for asthmatics 12 years and over.

Rochester : AAIR Research Center

Attention Those With Asthma: We Understand the Difficulties of Living with Asthma.

Rochester : AAIR Research Center

Does Your Child Suffer From Asthma? The triggers for asthma are all around us-colds, pets, pollen, pollution and even the weather.

Rochester : AAIR Research Center

Losing Control of Asthma Can Keep People From Doing the Things They Enjoy.

Rochester : AAIR Research Center

Seeking Volunteers with Asthma for an Investigational New Research Study

View More »

Bronx : Teva Investigational Site 10580

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Bronx : Vectura Clinical Trial Site 01004

Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma

Brooklyn : Teva Investigational Site 10187

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Corning : Call for Information (Investigational Site 0070)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Endwell : Call for Information (Investigational Site 0043)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Great Neck : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Great Neck :

A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)

Great Neck : North Shore-Long Island Jewish Health System, Division of Allergy/Immunology

The Effect of Montelukast on Asthma Control in Obese Asthmatic Children and Adolescents

Mineola : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

New Hyde Park : North Shore Diabetes and Endocrine Associates

Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease

New Hyde Park : Hofstra North Shore-LIJ School of Medicine

Long-acting Beta Agonist Step Down Study

New York : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

New York : New York Pulmonary Associates, P.C.

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

New York :

A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)

New York : Teva Investigational Site 10120

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

New York : MedHex Health

Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease

New York : New York University School of Medicine

Long-acting Beta Agonist Step Down Study

New York : Investigational Site

Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing

Newburgh : Teva Investigational Site 10532

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Newburgh : Teva Investigational Site 10190

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Newburgh : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

North Syracuse : Teva Investigational Site 10167

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Rochester : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Rochester : Allergy Asthma Immunology of Rochester (AAIR)

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Rochester : Call for Information (Investigational Site 0115) Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Rochester : Teva Investigational Site 10512

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Rochester : Teva Investigational Site 10112

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Rochester : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Rockville Centre : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Rockville Centre : 205.456.01001 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Valhalla : Maria Fareri Children's Hospital at Westchester Medical Center and New York Medical College

Long-acting Beta Agonist Step Down Study

North Carolina

Cary : PMG Research of Cary

Asthma Research Study: Do you, or does your child, have asthma?

Cary : PMG Research of Cary

Do you have Asthma?

Charlotte : American Health Research

16 week study for Patients with Asthma

Charlotte : American Health Research

16 week Study for Patients with Asthma being treated with Advair, Flovent or Equivalent

Charlotte : American Health Research

26 week study Comparing Advair to Flovent in Patients with Asthma

Greensboro : Research Site

A clinical research study for asthmatics 12 years and over.

Hickory : PMG Research of Hickory

Do you have Asthma?

High Point : Research Site

A clinical research study for asthmatics 12 years and over.

Wilmington : PMG Research of Wilmington

Do you have Asthma?

Winston-Salem : PMG Research of Winston-Salem

Do you have Asthma?

View More »

Charlotte : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Charlotte : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Charlotte : Teva Investigational Site 10244

Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma

Durham : Duke University

Bronchial Thermoplasty in Severe Persistent Asthma

Greensboro : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

High Point : Peters Medical Research

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

High Point : Call for Information (Investigational Site 0103) Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

High Point : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Raleigh : Teva Investigational Site 10057

A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma

Raleigh : North Carolina Clinical Research

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Raleigh : North Carolina Clinical Research

A Study of ARRY-502 in Patients With Persistent Asthma

Raleigh : Call for Information (Investigational Site 0117) Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Raleigh : Teva Investigational Site 10122

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Raleigh : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Raleigh : Teva Investigational Site 10448

Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects

Raleigh : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Raleigh : Novartis Investigative site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Shelby : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Winston-salem : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Winston-Salem : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Ohio

Akron : Research Site

A clinical research study for asthmatics 12 years and over.

Akron : Radiant Research - Akron

Clinical Research for Asthma

Canton : Research Site

A clinical research study for asthmatics 12 years and over.

Canton : Research Site

HZA 853/855 Asthma Studies for Children

Carlisle : Research Site

A clinical research study for asthmatics 12 years and over.

Cincinnati : Research Site

HZA 853/855 Asthma Studies for Children

Cleveland : Rapid Medical Research, Inc. (RMR)

Do You Have Trouble Controlling Your Asthma?

Columbus : Research Site

A clinical research study for asthmatics 12 years and over.

Dayton : Research Site

A clinical research study for asthmatics 12 years and over.

Sylvania : Research Site

A clinical research study for asthmatics 12 years and over.

View More »

Canton : Allergy, Respiratory & Sleep Center

A Study of ARRY-502 in Patients With Persistent Asthma

Canton : Teva Investigational Site 10522

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Canton : Teva Investigational Site 10194

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Canton : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Canton : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Canton : Call for Information (Investigational Site 9037)

Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)

Cincinnati : Call for Information (Investigational Site 0042)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Cincinnati : Call for Information (Investigational Site 0053)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Cincinnati : New Horizons Clinical Research

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Cincinnati : Bernstein Clinical Research

A Study of ARRY-502 in Patients With Persistent Asthma

Cincinnati :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Cincinnati : Call for Information (Investigational Site 0106) Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Cincinnati : Teva Investigational Site 10523

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Cincinnati : Teva Investigational Site 10507

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Cincinnati : Teva Investigational Site 10123

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Cincinnati : Teva Investigational Site 10107

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Cincinnati : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Cincinnati : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Cincinnati : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Cincinnati : 205.456.01005 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Cincinnati : 205.445.01001 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Cincinnati : 205.446.01005 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Cincinnati : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Cleveland :

A Non-drug Study Profiling Asthma

Cleveland : MetroHealth Medical Center

Acute Asthma Responsiveness and B2 Adrenergic Receptors Polymorphisms

Cleveland : Cleveland Clinic Foundation

Bronchial Thermoplasty in Severe Persistent Asthma

Cleveland : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Cleveland : The Cleveland Clinic

Evaluation of ST2 and IL-33 in Patients Presenting to the Emergency Department With Trouble Breathing

Columbus : Teva Investigational Site 10144

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Columbus : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Columbus : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Dayton : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Marion : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Middleburg Heights : Teva Investigational Site 11505

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Middleburg Heights : Teva Investigational Site 11115

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Middleburg Heights : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Stow : Call for Information (Investigational Site 0067)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Sylvania : Toledo Center for Clinical Research

A Study of ARRY-502 in Patients With Persistent Asthma

Sylvania : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Toledo : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Toledo :

A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)

Oklahoma

Oklahoma City : Research Site

A clinical research study for asthmatics 12 years and over.

Oklahoma City : Research Site

HZA 853/855 Asthma Studies for Children

Tulsa : Vital Prospects Clinical Research Institute, P.C.

Asthma

Tulsa : Vital Prospects Clinical Research Institute, P.C.

Uncontrolled Asthma

View More »

Norman : Ekips Technologies, Inc.

Development of a Breath Analyzer for Asthma Screening

Oklahoma :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Oklahoma City : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Oklahoma City : Allergy, Asthma & Clinical Research Center

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Oklahoma City : Allergy Asthma & Clinical Research Center

A Study of ARRY-502 in Patients With Persistent Asthma

Oklahoma City : IPS Research Company

A Study of ARRY-502 in Patients With Persistent Asthma

Oklahoma City :

A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)

Oklahoma City : Teva Investigational Site 10560

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Oklahoma City : Teva Investigational Site 10574

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Oklahoma City : Teva Investigational Site 10579

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Oklahoma City : Teva Investigational Site 10160

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Oklahoma City : Teva Investigational Site 10174

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Oklahoma City : Teva Investigational Site 10198

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Oklahoma City : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Oklahoma City :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Oklahoma City : 205.445.01010 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Oklahoma City : 205.446.01010 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Oklahoma City : 205.443.12005 Boehringer Ingelheim Investigational Site

Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

Oklahoma City : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Oklahoma City : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Tulsa : Vital Prospects Clinical Research Institute, PC

A Study of ARRY-502 in Patients With Persistent Asthma

Tulsa :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Oregon

Eugene : Clinical Trials of America, Inc

Do you, or does your child (12 years or older), have asthma?

Medford : Research Site

A clinical research study for asthmatics 12 years and over.

Medford : Sunstone Medical Research, LLC

Currently seeking individuals with persistent asthma to participant in a Clinical Research Study.

Medford : Research Site

HZA 853/855 Asthma Studies for Children

Portland : Research Site

A clinical research study for asthmatics 12 years and over.

View More »

Ashland : Teva Investigational Site 10598

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Eugene : Allergy & Asthma Research Group

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Eugene : Teva Investigational Site 10132

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Gresham : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Lake Oswego : Baker Allergy, Asthma & Dermatology Research Center

A Study of ARRY-502 in Patients With Persistent Asthma

Lake Oswego : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Medford : Teva Investigational Site 10056

A 12-week Study to Compare the Efficacy and Safety of Albuterol Spiromax® Versus a Placebo in People 12 Years and Older With Persistent Asthma

Medford : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Medford : Clinical Research Inst. of Southern Oregon, PC

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Medford : Clinical Research Institute of Southern Oregon

A Study of ARRY-502 in Patients With Persistent Asthma

Medford :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Medford : Teva Investigational Site 10135

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Medford : Amphastar Site 2

Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation

Medford : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Medford : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Medford : Teva Investigational Site 10451

Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects

Medford : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Medford : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

Medford : The Clinical Research Institute of Southern Oregn, PC

Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma

Portland : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Portland : Call for Information (Investigational Site 0061)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Portland : Allergy Associates Research Center

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Portland : Teva Investigational Site 10142

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Portland : Teva Investigational Site 10449

Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects

Portland : 205.445.01005 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Portland : Transitional Clinical Research, Inc. Allergy Associates Research Center

Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma

Portland : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Pennsylvania

Bethlehem : Research Site

A clinical research study for asthmatics 12 years and over.

Blue Bell : Allergy & Asthma Specialists, P.C.

Currently enrolling asthmatics that are not well controlled on current asthma therapy.

Levittown : Research Site

A clinical research study for asthmatics 12 years and over.

Philadelphia : Research Site

A clinical research study for asthmatics 12 years and over.

Phoenixville : Research Site

A clinical research study for asthmatics 12 years and over.

Pittsburgh : Research Site

HZA 853/855 Asthma Studies for Children

Upland : Research Site

A clinical research study for asthmatics 12 years and over.

Wyomissing : Research Site

A clinical research study for asthmatics 12 years and over.

View More »

Altoona : Teva Investigational Site 10509

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Blue Bell : Investigational Site

Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing

Blue Bell : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Collegeville : Call for Information (Investigational Site 9035)

Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)

Dubois : DuBois Regional Medical Center

Bronchial Thermoplasty in Severe Persistent Asthma

Erie : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Feasterville : Call for Information (Investigational Site 0065)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Harrisburg :

A Study of Lebrikizumab in Patients Whose Asthma is Uncontrolled With Inhaled Corticosteroids and A Second Controller Medication (LUTE)

Hershey : Pennsylvania State Hershey

Bronchial Thermoplasty in Severe Persistent Asthma

Hershey : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Philadelphia : Call for Information (Investigational Site 0062)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Philadelphia :

A Non-drug Study Profiling Asthma

Philadelphia : Teva Investigational Site 10555

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Philadelphia : Teva Investigational Site 10183

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Philadelphia : University of Pennsylvania

Bronchial Thermoplasty in Severe Persistent Asthma

Philadelphia : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Pittsburgh : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Pittsburgh : Call for Information (Investigational Site 0071)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Pittsburgh : Allergy & Clinical Immunology Associates

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Pittsburgh : University of Pittsburgh Asthma Institute

A Study of ARRY-502 in Patients With Persistent Asthma

Pittsburgh :

A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)

Pittsburgh : Teva Investigational Site 10566

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Pittsburgh : Teva Investigational Site 10166

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Pittsburgh : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Pittsburgh : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Pittsburgh : Research Site

Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects

Pittsburgh : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Upland : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Upland : Call for Information (Investigational Site 0051)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Upland : Teva Investigational Site 10521

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Upland : Teva Investigational Site 10121

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Wyomissing : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Rhode Island

East Providence : Research Site

A clinical research study for asthmatics 12 years and over.

View More »

East Providence : Teva Investigational Site 11119

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Lincoln :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Lincoln : Teva Investigational Site 10581

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Lincoln : Teva Investigational Site 10181

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Lincoln : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Lincoln : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Providence :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Providence : Teva Investigational Site 10562

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Providence : Teva Investigational Site 10162

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Warwick : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Warwick :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Warwick : Call for Information (Investigational Site 9053)

Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)

South Carolina

Charleston : Research Site

A clinical research study for asthmatics 12 years and over.

Charleston : Research Site

HZA 853/855 Asthma Studies for Children

Charleston : Research Site

HZA 853/855 Asthma Studies for Children

Easly : Research Site

A clinical research study for asthmatics 12 years and over.

Fort Mill : Piedmont Research Partners, LLC Updated

Asthma

Greer : Radiant Research - Greer

Asthma Research Study

Orangeburg : Research Site

HZA 853/855 Asthma Studies for Children

View More »

Charleston : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Charleston : National Allergy, Asthma and Uticaria Center of Charleston

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Charleston : National Allergy, Asthma, and Uticaria Centers

A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma

Charleston : Teva Investigational Site 10526

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Charleston : Teva Investigational Site 10126

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Charleston : Teva Investigational Site 10149

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Charleston : Medical University of South Carolina

Bronchial Thermoplasty in Severe Persistent Asthma

Charleston : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Charleston : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Charleston :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Charleston : 205.445.01006 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Charleston : 205.446.01002 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Charleston : 205.446.01004 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Fort Mill : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Fort Mill : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Gaffney : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Greenville : Greenville Pharmaceutical research, Inc.

12-Week Study in Adult Subjects With Asthma

Greenville : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Greenville : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Greenville :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Mt. Pleasant : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Orangeburg : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Orangeburg : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Orangeburg : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

Rock Hill : CU Pharmaceutical Research

A 12-Week Study in Adult Subjects With Asthma

Spartanburg : Teva Investigational Site 11515

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Spartanburg : Teva Investigational Site 11131

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Spartanburg : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Spartanburg : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma

Spartanburg : Teva Investigational Site 10228

Efficacy of Inhaled Albuterol Spiromax® in Subjects With Persistent Asthma

Spartanburg : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

Summerville : 205.456.01006 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Summerville : 205.443.12004 Boehringer Ingelheim Investigational Site

Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

Tennessee

Bristol : PMG Research of Bristol

Do you have Asthma?

Knoxville : PMG Research of Knoxville

Do you have Asthma?

View More »

Bristol : Call for Information (Investigational Site 0066)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Chattanooga : Call for Information (Investigational Site 0049)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Kingsport : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Nashville : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Texas

Austin : Research Site

HZA 853/855 Asthma Studies for Children

Dallas : DallasAllergyImmunology Research

A 12 Month, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Reslizumab (3.0 mg/kg) in the Reduction of Clinical Asthma Exacerbations in Patients (12-75 Years of Age) With Eosinophillic Asthma

Dallas : DallasAllergyImmunology Research

A 12-Week, Randomized, Placebo-Controlled, Dose-Ranging, Efficacy and Safety Study of Mometasone Furoate Metered Dose Inhaler in the Treatment of Children Ages 5 to 11 Years With Persistent Asthma

Dallas : DallasAllergyImmunology Research

A 6-month safety and benefit study of inhaled fluticasone propionate/ salmeterol combination versus inhaled fluticasone propionate in the treatment of 6,200 pediatric subjects 4-11 years old with persistent asthma

Dallas : Research Site

A clinical research study for asthmatics 12 years and over.

Dallas : Research Site

A clinical research study for asthmatics 12 years and over.

Dallas : DallasAllergyImmunology Research

A dose-ranging study of fluticasone furoate (FF) inhalation powder in children aged 5-11 years with asthma.

Dallas : DallasAllergyImmunology Research

A Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children Aged 5-11 Years With Asthma on a Background of Inhaled Corticosteroid Therapy

Dallas : DallasAllergyImmunology Research

A Safety and Efficacy Study of Inhaled Fluticasone Propionate/Salmeterol Combination Versus Inhaled Fluticasone Propionate in the Treatment of Adolescent and Adult Subjects With Asthma.

Dallas : Radiant Research - Dallas, North

Asthma Research Study

Dallas : ACRC TRIALS

Asthma?

Dallas : Radiant Research - Dallas, North

Clinical Research for Asthma

Dallas : Pharmaceutical Research & Consulting, Inc.

Do you have asthma?

El Paso : Research Site

A clinical research study for asthmatics 12 years and over.

El Paso : Research Site

A clinical research study for asthmatics 12 years and over.

El Paso : Research Site

A clinical research study for asthmatics 12 years and over.

Fort Worth : Research Site

A clinical research study for asthmatics 12 years and over.

San Antonio : Research Site

A clinical research study for asthmatics 12 years and over.

San Antonio : Research Site

A clinical research study for asthmatics 12 years and over.

San Antonio : Radiant Research - San Antonio

Clinical Research Study for Asthma

San Antonio : Lung Diagnostics

Clinical research study for patients with Moderate-Severe Asthma

San Antonio : Research Site

HZA 853/855 Asthma Studies for Children

Waco : Allergy Asthma Research Institute

Adult Asthma Study

Waco : Allergy Asthma Research Institute

Do you suffer from Asthma?

Waco : Research Site

HZA 853/855 Asthma Studies for Children

Waco : Allergy Asthma Research Institute

Infants and toddlers with asthma symptoms (coughing, wheezing, shortness of breath).

Waco : Allergy Asthma Research Institute

Pediatric Asthma Study

View More »

Arlington :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Austin : Tekton Research

A Study of ARRY-502 in Patients With Persistent Asthma

Austin :

A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)

Austin : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Boerne : Hill Country Family Medical Center

A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma

Boerne : Call for Information (Investigational Site 0110) Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Boerne : Teva Investigational Site 10519

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Boerne : Teva Investigational Site 10119

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Corsicana : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Dallas : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Dallas : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Dallas : Pharmaceutical Research & Consulting, Inc.

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Dallas : Allergy/Immunology Research Center of North Texas

A Safety, Efficacy and Tolerability Study in Pediatric Subjects With Asthma

Dallas : Pharmaceutical Research & Consulting Inc.

A Study of ARRY-502 in Patients With Persistent Asthma

Dallas : Call for Information (Investigational Site 0129) Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Dallas : Teva Investigational Site 10542

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Dallas : Teva Investigational Site 10141

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Dallas : Teva Investigational Site 10192

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Dallas : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Dallas : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Dallas : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Dickinson : Call for Information (Investigational Site 0039)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Dickinson : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

El Paso : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

El Paso : Western Sky Medical Research, Inc.

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

El Paso : Western Sky Medical Research Inc

A Study of ARRY-502 in Patients With Persistent Asthma

El Paso :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

El Paso : Teva Investigational Site 10548

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

El Paso : Teva Investigational Site 10148

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

El Paso : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

El Paso : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

El Paso : Western Sky Medical Research

Comparing Bronchodilation of Symbicort With and With Out Valved Holding Chamber (Aerochamber Plus)

El Paso : Teva Investigational Site 10457

Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects

El Paso : 205.445.01004 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

El Paso : Western Sky Medical

Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma

El Paso : Allergy and Asthma Center of El Paso

Onset of Action of Advair Hydrofluoroalkane (HFA) 115/21 in Comparison to Symbicort Pressurised Metered-Dose Inhalers (pMDI) 160/4.5 Measured by Impulse Oscillometry (IOS)

El Paso : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Fort Worth : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Fort Worth : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Fort Worth : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Forth Worth : Call for Information (Investigational Site 0119) Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Forth Worth : Teva Investigational Site 11512

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Georgetown : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Houston : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Houston : Call for Information (Investigational Site 0057)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Houston : Call for Information (Investigational Site 0056)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Houston : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Houston : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Live Oak : Live Oak Allergy & Asthma Clinic

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

McKinney : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

New Braunfels : Central Texas Health Research

A Study of ARRY-502 in Patients With Persistent Asthma

New Braunfels : Amphastar Site 3

Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation

New Braunfels : Teva Investigational Site 10450

Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects

New Braunfels : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

San Antonio : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

San Antonio : Call for Information (Investigational Site 9180)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

San Antonio : Sylvana Research Associates

A Study of ARRY-502 in Patients With Persistent Asthma

San Antonio :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

San Antonio : Call for Information (Investigational Site 0113) Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

San Antonio : Call for Information (Investigational Site 0108) Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

San Antonio : Teva Investigational Site 10569

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

San Antonio : Teva Investigational Site 10515

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

San Antonio : Teva Investigational Site 10115

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

San Antonio : Amphastar Site 4

Albuterol DPI (A006) Clinical Study-B2: Efficacy, Dose-Ranging and Initial Safety Evaluation

San Antonio : Allergy & Asthma Center, PA

CYT003-QbG10, a TLR9-agonist, for Treatment of Uncontrolled Moderate to Severe Allergic Asthma

San Antonio : Teva Investigational Site 10456

Dose Ranging Study of the Salmeterol Component of Fluticasone /Salmeterol Spiromax Compared to Fluticasone Spiromax and Advair Diskus in Asthma Subjects

San Antonio : SAM Clinical Research Center

Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease

San Antonio : Sylvana Research Assocaites

Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma

San Antonio : Investigational Site

Pharmacosurveillance Data Repository of Patients With and Without History of Anaphylactic Reactions Subsequent to Xolair Dosing

San Antonio : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Spring : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Sugar Land :

A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)

Sugarland : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Sugarland :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Waco : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Waco : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Waco : Call for Information (Investigational Site 0038)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Waco : Allergy Asthma Research Institute

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Waco : Allergy & Asthma Care of Waco, PA

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Waco :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Waco : Call for Information (Investigational Site 0101) Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Waco : Teva Investigational Site 10103

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Waco : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Waco : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Waco : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Waco : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Utah

Bountiful : Research Site

A clinical research study for asthmatics 12 years and over.

Draper : Research Site

A clinical research study for asthmatics 12 years and over.

Salt Lake City : Research Site

A clinical research study for asthmatics 12 years and over.

Salt Lake City : Optimum Clinical Research, Inc.

Asthma. Prevention of asthma related complications.

West Jordan : Advanced Clinical Research, UT

Do You Have Trouble Controlling Your Asthma?

View More »

Midvale : Call for Information (Investigational Site 0054)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Murray : Call for Information (Investigational Site 9050)

Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)

Provo : Teva Investigational Site 10576

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Vermont

Queen City : Research Site

HZA 853/855 Asthma Studies for Children

View More »

South Burlington : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

South Burlington : Teva Investigational Site 10534

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

South Burlington : Teva Investigational Site 10134

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

South Burlington : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

South Burlington : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

South Burlington : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Virginia

Midlothian : Virginia Research Center

Adolescent and Adult Subjects With Asthma

Newport News : Research Site

A clinical research study for asthmatics 12 years and over.

Newport News : Health Research of Hampton Roads, Inc.

Asthma Research

Richmond : Research Site

A clinical research study for asthmatics 12 years and over.

Richmond : Virginia Research Center

Adolescent and Adult Subjects With Asthma

Richmond : Pulmonary Associates of Richmond, Inc.

Asthma takes the air out of your game.

View More »

Abingdon : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Burke : Teva Investigational Site 10159

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Charlottesville : University of Virginia Medical Center

Bronchial Thermoplasty in Severe Persistent Asthma

Charlottesville : University of Virginia

Long-acting Beta Agonist Step Down Study

Danville : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Fairfax : Teva Investigational Site 10502

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Fairfax : Teva Investigational Site 10102

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Manassas : Teva Investigational Site 10595

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Richmond : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Richmond : Call for Information (Investigational Site 0107) Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Richmond : Teva Investigational Site 10508

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Richmond : Teva Investigational Site 10108

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Richmond : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Richmond : Pulmonary Associates of Richmond

Bronchial Thermoplasty in Severe Persistent Asthma

Springfield :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Vienna : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Virginia Beach : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Washington

Vancouver : Research Site

A clinical research study for asthmatics 12 years and over.

View More »

Kirkland : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Seattle : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Seattle : ASTHMA, Inc.

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Seattle : Asthma Inc.

A Study of ARRY-502 in Patients With Persistent Asthma

Seattle : ASTHMA, Inc. Clinical Research Center

Evaluation of Efficacy and Safety for Single Dose of E004 in Children With Asthma

Seattle : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Spokane :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Spokane : Teva Investigational Site 10124

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Tacoma : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Tacoma : MultiCare Pulmonary Specialists

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Tacoma : Teva Investigational Site 10530

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Tacoma : Teva Investigational Site 11511

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Tacoma : Teva Investigational Site 11117

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Tacoma : Teva Investigational Site 11125

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Tacoma : Franciscan Research Center (St. Joseph Medical Center)

Bronchial Thermoplasty in Severe Persistent Asthma

Tacoma : MultiCare Pulmonary Specialists

Bronchial Thermoplasty in Severe Persistent Asthma

Tacoma : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Wisconsin

Milwuakee : Research Site

A clinical research study for asthmatics 12 years and over.

View More »

Greenfield : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Greenfield : Allergy Asthma & Sinus Center, S.C.

A Study of ARRY-502 in Patients With Persistent Asthma

Greenfield :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Greenfield : Teva Investigational Site 10570

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Greenfield : Teva Investigational Site 10170

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Madison : Call for Information (Investigational Site 0060)

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Madison : Asthma Allergy & Pulmonary Research

A Study of ARRY-502 in Patients With Persistent Asthma

Madison :

A Study of Lebrikizumab in Patients With Uncontrolled Asthma Who Are on Inhaled Corticosteroids and A Second Controller Medication (VERSE)

Madison : University of Wisconsin

Bronchial Thermoplasty in Severe Persistent Asthma

Madison : University of Wisconsin Madison Department of Asthma, Allergy and Pulmonary Clinical Research

Mannitol Bronchoprovocation Challenge Ancillary Study/ACRN

Madison : Research Site

Phase 1, Randomized, Placebo-controlled, Dose-escalation Safety Study of MEDI4212 in Allergic Subjects

Milwaukee : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Milwaukee :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Milwaukee : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

West Allis : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Argentina

Berazategui : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Buenos Aires : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Buenos Aires : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Buenos aires : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Buenos Aires : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

View More »

Buenos Aires : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

Capital Federal : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Capital Federal : 205.456.54002 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Capital Federal : 205.456.54008 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Capital Federal : 205.456.54006 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Capital Federal : 205.446.54003 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Capital Federal : 205.446.54002 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Ciudad Autonoma de Buenos Aires : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

Ciudad Autónoma de Buenos Aires : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Ciudad Autónoma de Buenos Aires : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

Ciudad de Buenos Aires : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Florencio Varela : 205.456.54003 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

La Plata : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Mar Del Plata : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Mar del Plata : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Mar del Plata : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Mendoza : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Mendoza : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Mendoza : 205.456.54005 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Mendoza : 205.446.54004 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Mendoza : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Mendoza : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

Monte Grande : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Nueve de Julio : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Quilmes : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Ranelagh : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Rosario : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Rosario : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Salta : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

San Miguel de Tucuman : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

San Miguel de Tucuman : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

San Miguel de Tucuman : 205.456.54009 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

San Miguel de Tucumán : 205.456.54004 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

San Miguel de Tucumán : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

Santa Fe : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Santa Fe : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Tucuman : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Tucumán : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

Australia

Adelaide : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Bedford Park : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Clayton : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Herston : 205.456.61003 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Melbourne : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

View More »

Nedlands : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Nedlands : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Nedlands : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

New Lambton : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

New Lambton : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Parkville : 205.456.61002 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Perth :

Effect of KB003 in Subjects With Asthma Inadequately Controlled by Corticosteroids

Perth : 205.456.61001 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Austria

Feldbach : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Grieskirchen : 205.441.43004 Boehringer Ingelheim Investigational Site

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

Grieskirchen : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Linz : 205.441.43003 Boehringer Ingelheim Investigational Site

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

Linz : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

View More »

Thalheim bei Wels : 205.441.43001 Boehringer Ingelheim Investigational Site

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

Thalheim bei Wels : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Vienna : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Wels : 205.441.43002 Boehringer Ingelheim Investigational Site

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

Belgium

Antwerp :

A Study of CNTO 3157 in Healthy Normal and Asthmatic Participants Inoculated With Human Rhinovirus Type 16

Brussel : 205.443.01002 Boehringer Ingelheim Investigational Site

Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

Brussels : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Brussels : GSK Investigational Site

Inhalation of Corticosteroids in Smoking and Non-smoking Asthmatics.

Edegem (Antwerp) : University Hospital of Antwerp

Study to Assess the Effect of the NEXThaler® Device (DPI - Dry Powder Inhaler) on the Central and Peripheral Airway Dimensions in Asthmatic Patients

View More »

Gent : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Hasselt : 205.443.01003 Boehringer Ingelheim Investigational Site

Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

Leuven : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Liège : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Brazil

Belo Horizonte : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Florianopolis : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Porto Alegre : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Rio de Janeiro : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Salvador : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

View More »

Sao Paulo : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Bulgaria

Burgas : Teva Investigational Site 59107

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Gotse Delchev : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Lovech : Teva Investigational Site 59103

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Petrich : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Pleven : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

View More »

Pleven : Teva Investigational Site 59106

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Plovdiv : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Plovdiv : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Plovdiv : 205.456.35902 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Ruse : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Ruse : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Ruse : Teva Investigational Site 59104

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Ruse : 205.456.35901 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Russe : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Sofia : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Sofia : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Sofia : Teva Investigational Site 59501

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Sofia : Teva Investigational Site 59101

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Sofia : Teva Investigational Site 59102

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Sofia : Teva Investigational Site 59105

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Sofia : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Sofia : 205.456.35903 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Sofia : 205.445.35901 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Sofia : 205.445.35902 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Sofia : 205.445.35903 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Sofia : 205.445.35904 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Varna : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Canada

Alberta : Calgary Clinical Site 540

A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With Asthma

Brampton : Novartis Investigative Site

Efficacy, Safety and Pharmacokinetics of Indacaterol Acetate in Patients With Persistent Asthma

Burlington : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Calgary :

A Non-drug Study Profiling Asthma

Calgary : Research Site

Double-blind, Multiple Dose Study in Subjects With Mild Atopic Asthma

View More »

Calgary : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Calgary : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Edmonton : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Edmonton : University of Alberta Hospital

Tiotropium for Smoking Asthmatics Study

Hamilton : Joseph Greenbaum, MD

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Hamilton : McMaster Medical Center

CSL311 and Cell Viability in Asthma

Hamilton : Research Site

Double-blind, Multiple Dose Study in Subjects With Mild Atopic Asthma

Hamilton : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Kirkland : Merck Frosst Canada Ltd.

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Kirkland : Merck Frosst Canada Ltd.

Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)

Missassauga : Cheema Research, Inc.

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Mississauga : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Montreal : Montreal Chest Institute

Bronchial Thermoplasty in Severe Persistent Asthma

Montreal : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Montreal : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Niagara Falls : Niagara Clinical Research

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Ontario : Hamilton Clinical Site 550

A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With Asthma

Ottawa : Ottawa Allergy Research Corp

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Ottawa : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Pointe-Claire : Dynamik Research, Inc.

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Quebec : Research Site

A Phase II Study to Evaluate the Efficacy, Safety and Tolerability of AZD5069 in Patients With Uncontrolled Persistent Asthma.

Quebec : Centre De recherche Appliquee en Allergie DeQuebec

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Quebec : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Quebec City : Quebec Clinical Site 510

A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With Asthma

Quebec City : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Quebec City : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Quebec City : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Sainte Foy :

A Non-drug Study Profiling Asthma

Sainte-Foy : Hospital Laval Centre de Pneumologie

Bronchial Thermoplasty in Severe Persistent Asthma

Sainte-Foy : Research Site

Double-blind, Multiple Dose Study in Subjects With Mild Atopic Asthma

Saskatoon : Saskatoon Clinical Site 520

A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With Asthma

Saskatoon : Research Site

Double-blind, Multiple Dose Study in Subjects With Mild Atopic Asthma

St-Charles-Borromée : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Surrey : Surrey Memorial Hospital

Bronchial Thermoplasty in Severe Persistent Asthma

Toronto : Primary Care Lung Clinic

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Toronto : Pulmonary Care Clinic

A Safety and Efficacy Study of Inhaled R940343 in Patients With Mild to Moderate Asthma

Toronto : GSK Investigational Site

A Study to Investigate the Safety, Pharmacodynamics and Efficacy Against Allergic Reactivity of Repeat Intranasal Administration of the TLR7 Agonist GSK2245035 in Subjects With Respiratory Allergies

Toronto : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Toronto : The Hospital for Sick Children

Use of Montelukast to Treat Children With Mild to Moderate Acute Asthma

Trois Rivieres : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Vancouver :

A Non-drug Study Profiling Asthma

Vancouver : Vancouver Clinical Site 530

A Placebo and Active Controlled Study of ONO-6950 Following Allergen Challenge in Patients With Asthma

Vancouver : Vancouver General Hospital, University of British Columbia

Bronchial Thermoplasty in Severe Persistent Asthma

Vancouver : Research Site

Double-blind, Multiple Dose Study in Subjects With Mild Atopic Asthma

Vancouver : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Vancouver : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Winnipeg : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Chile

Puente Alto - Santiago : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Puente Alto - Santiago : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

Puente Alto - Santiago : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Quillota : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Quillota : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

View More »

Rancagua : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Santiago : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Santiago : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Santiago : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Santiago : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Santiago : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

Santiago : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

Santiago : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Talca : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

Talcahuano : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Talcahuano : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Valparaiso : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Valparaiso : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

Valparaiso : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Vina Del Mar : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Viña del Mar : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

China

Beijing : Capital Institute of Pediatrics Updated

Bronchodilator Response in 4-12 Years Chinese Controller Naive Asthmatic Children

Beijing : The Second Artillery General Hospital of PLA

Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma

Beijing : GSK Investigational Site

Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma

Beijing : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry

Beijing : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.

View More »

Beijing : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Beijing : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Changchun : GSK Investigational Site

Efficacy and Safety of Fluticasone Nebules in Chinese Asthmatic Pediatric and Adolescent Subjects With an Acute Exacerbation

Changchun : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Changsha : GSK Investigational Site

Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma

Changsha : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Changsha City : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Chengdu : GSK Investigational Site

Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma

Chengdu : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Chongqing : GSK Investigational Site

Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma

Chongqing : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.

Chongqing : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Foshan : The First Affiliated Hospital of Foshan

Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma

Guang zhou : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Guangzhou : Guangzhou Institute of Respiratory Disease

Effects of Leukotriene Modulator Montelukast on Cough Variant Asthma

Guangzhou : The First Affiliated Hospital of Guangzhou Medical College, Guangzhou Institute of Respiratory Disease

Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma

Guangzhou : Guangzhou First Municipal People's Hospital

Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma

Guangzhou : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Haikou : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.

Hang Zhou : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.

Hangzhou : GSK Investigational Site

Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma

Hangzhou : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.

Hangzhou : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Jinan : GSK Investigational Site

Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma

Nanchang : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Nanjing : Zhongda Hospital of Southeast University

Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma

Nanjing : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Nanjing : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Nanning : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.

Nanning : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Qingdao : GSK Investigational Site

Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma

Qingdao : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.

Shanghai : GSK Investigational Site

Efficacy and Safety of Fluticasone Nebules in Chinese Asthmatic Pediatric and Adolescent Subjects With an Acute Exacerbation

Shanghai : Dongfang Hospital Affiliated to Tongji University

Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma

Shanghai : Zhongshan Hospital affiliated to Fudan University

Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma

Shanghai : Putuo District Hospital

Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma

Shanghai : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.

Shanghai : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Shanghai : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Shengyang : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Shenyang : GSK Investigational Site

Efficacy and Safety of Fluticasone Nebules in Chinese Asthmatic Pediatric and Adolescent Subjects With an Acute Exacerbation

Shenyang : Shengjing Hospital

Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma

Shenyang : The General Hospital of Shenyang Military Region

Efficacy and Safety Study of Budesonide Novolizer Dry Powder Inhaler 200μg to Treat Chinese Patients With Mild to Moderate Asthma

Shenyang : GSK Investigational Site

Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma

Shenyang : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.

Shenyang : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Shenzhen : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.

Shijiazhuang : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Suzhou : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Taiyuan : GSK Investigational Site

Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma

Wenzhou : GSK Investigational Site

Efficacy and Safety of Fluticasone Nebules in Chinese Asthmatic Pediatric and Adolescent Subjects With an Acute Exacerbation

Wuhan : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Wuxi : GSK Investigational Site

Efficacy and Safety of Fluticasone Nebules in Chinese Asthmatic Pediatric and Adolescent Subjects With an Acute Exacerbation

Wuxi : GSK Investigational Site

Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma

Xian : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.

Xian : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Xi'an : Novartis Investigative Site

Omalizumab in Patients With Moderate to Severe Persistent Allergic Asthma Not Adequately Controlled Despite GINA (2009) Step 4 Therapy

Xuzhou : GSK Investigational Site

Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma

Yinchuan : GSK Investigational Site

Efficacy and Safety Study of Fluticasone Proponate Inhalation Solution in Adult and Adolescent Asthma

Yinchuan : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.

Zhanjiang : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.

Colombia

Armenia : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Barranquilla : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Barranquilla : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Bogota : MDS Colombia SAS Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Bogota : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

View More »

Bogota : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Bogota : MDS Colombia SAS

Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)

Bogotá : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Croatia

Split : Teva Investigational Site 85105

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Zagreb : Merck Sharp & Dohme d.o.o Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Zagreb : Teva Investigational Site 85102

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Zagreb : Teva Investigational Site 85103

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Zagreb : Teva Investigational Site 85104

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Czech Republic

Beroun : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Boskovice : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Breclav : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Breclav : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Brno : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

View More »

Brno : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Brno - Bohunice : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Hradec Kralove : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Jablonec nad Nisou : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Jihlava : 205.446.42001 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Kladno : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Krnov : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Kutna Hora : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Kutna Hora : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Liberec : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Litomerice : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Most : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Olomouc : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Ostrava : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Ostrava-Marianske Hory : Alergologie Skopkova s.r.o

Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients

Plzen : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Plzen : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Prague : 205.446.42002 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Prague : 205.446.42003 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Prague : 205.446.42004 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Praha : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Praha : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Praha 4 : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Praha 8 : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Rokycany : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Tabor : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Teplice : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Trutnov : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Denmark

Aarhus C : Research Dept. of Respiratory Medicine, Aarhus University Hospital

Daily Magnesium-supplement for Severe Asthmatics

Kobenhavn Nv :

A Non-drug Study Profiling Asthma

Estonia

Tallinn : Merck Sharp & Dohme OU Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Finland

Espoo : Orion Pharma Clinical Pharmacology Unit

Comparison of Salmeterol and Fluticasone Propionate Absorption From Salmeterol/Fluticasone Easyhaler and Seretide Diskus

Helsinki : 205.443.02002 Boehringer Ingelheim Investigational Site

Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

Turku : 205.443.02003 Boehringer Ingelheim Investigational Site

Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

France

Beuvry : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Bordeaux Pessac N/A :

A Non-drug Study Profiling Asthma

Gières : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Le Kremlin-Bicêtre Cedex : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Le Kremlin-Bicêtre Cedex : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

View More »

Lille Cedex : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Lyon cedex 04 : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Lyon cedex 04 : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Marseille :

A Non-drug Study Profiling Asthma

Marseille cedex 20 : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Marseille cedex 20 : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Montpellier : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Montpellier : CHU Arnaud de Villeneuve

Safety Study of Sublingual Immunotherapy Tablets of House Dust Mite Allergen Extracts

Montpellier cedex 5 : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Montpellier cedex 5 : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Montpellier cedex 5 : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Nantes cedex 1 : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Paris : Bichat Hospital

Bicentric Prospective Study, Evaluating Bronchial THERMOPLASTY in a Patient Presenting Severe Uncontrolled Asthma

Paris : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Paris Cedex 18 : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Perpignan : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Perpignan : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Pessac : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Reims : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Saint Pierre cedex : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Saint Pierre cedex : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Strasbourg : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Strasbourg Cedex : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Tarbes Cedex : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Germany

Aschaffenburg : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Aschaffenburg : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Berlin : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Berlin : Vectura Clinical Trial Site 03006

Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma

Berlin : 205.441.49015 Boehringer Ingelheim Investigational Site

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

View More »

Berlin : Hautarztpraxis

Depigoid Birch 5000 Longterm Study in Adults and Adolescents

Berlin : Hippke, Ear-Nose-Throat specialist

Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma

Berlin : Nycomed Investigational Site

Effect of High Dose Ciclesonide on Asthma Control

Berlin : 205.456.49008 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Berlin : 205.445.49015 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Berlin : 205.445.49012 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Berlin : 205.446.49015 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Berlin : 205.446.49012 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Berlin : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Berlin : 205.443.03003 Boehringer Ingelheim Investigational Site

Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

Berlin : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Berlin : Charité Research Organisation GmbH

Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose)

Bochum : 205.456.49001 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Bochum : 205.445.49001 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Bochum : 205.446.49001 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Bochum : 205.443.03001 Boehringer Ingelheim Investigational Site

Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

Bonn : Nycomed Investigational Site

Effect of High Dose Ciclesonide on Asthma Control

Dresden : 205.445.49007 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Dresden : 205.446.49007 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Elgershausen. Greifenstein : Lungenfachklinik Waldhof Elgershausen

Inhaled Steroids and Control of Severe Asthma

Ettenheim : 205.445.49004 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Ettenheim : 205.446.49004 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Ettenheim : 205.443.03002 Boehringer Ingelheim Investigational Site

Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

Frankfurt :

A Non-drug Study Profiling Asthma

Frankfurt : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Frankfurt : 205.441.49003 Boehringer Ingelheim Investigational Site

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

Frankfurt : 205.441.49014 Boehringer Ingelheim Investigational Site

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

Frankfurt : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Frankfurt : 205.456.49004 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Frankfurt : 205.445.49003 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Frankfurt : 205.446.49003 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Frankfurt : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Frankfurt : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Frankfurt : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Frankfurt : Clinical Research Centre RespiratoryMedicine (IKF)

Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose)

Frankfurt am Main : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Gauting : Inamed GmbH

Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose)

Geesthacht : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Gelnhausen : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Gelnhausen : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Giessen : Justus-Liebig-University Giessen

Inhaled Steroids and Control of Severe Asthma

Grosshansdorf : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Großhansdorf : 205.441.49007 Boehringer Ingelheim Investigational Site

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

Grosshansdorf : Pulmonary Research Institute (PRI)

Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose)

Grosshansdorf : Novartis Investigative Site

Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma

Haar : MSD Sharp & Dohme GMBH

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Haar : MSD Sharp & Dohme GMBH

Study to Evaluate the Effectiveness and Safety of MK-1029 in the Treatment of Persistent Asthma That is Not Controlled With Montelukast (ML) in Adults (MK-1029-011 AM2)

Hamburg : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Hamm : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Hannover : 205.441.49005 Boehringer Ingelheim Investigational Site

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

Hannover : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Hannover : Clinical Airway Research Fraunhofer Institute for Toxicology and Experimental Medicine (ITEM)

Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose)

Hannover : Novartis Investigative Site

Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma

Jena : 205.456.49009 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Jena : 205.445.49005 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Jena : 205.446.49005 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Kehl : 205.456.49005 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Kehl : 205.445.49008 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Kehl : 205.446.49008 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Kleve-Materborn : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Koblenz : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Koblenz : 205.456.49003 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Koblenz : 205.445.49009 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Koblenz : 205.446.49009 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Landsberg : Nycomed Investigational Site

Effect of High Dose Ciclesonide on Asthma Control

Leipzg : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Leipzig : 205.441.49004 Boehringer Ingelheim Investigational Site

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

Lübeck : 205.441.49010 Boehringer Ingelheim Investigational Site

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

Luebeck : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Luebeck : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Magdeburg : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Magdeburg : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Magdeburg : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Mainz : 205.456.49010 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Mainz : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Mainz : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Mainz : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Mainz : Johannes Gutenberg University Medical Clinic III for Hematology, Oncology and Pneumology

Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose)

Mainz : Novartis Investigative Site

Safety, Tolerability, and Efficacy of AIN457 in Patients With Uncontrolled Asthma

Mannheim : 205.441.49013 Boehringer Ingelheim Investigational Site

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

Marburg : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Marburg : 205.445.49014 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Marburg : 205.446.49014 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Mönchengladbach : 205.445.49011 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Mönchen-Gladbach : 205.456.49006 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Mönchen-Gladbach : 205.446.49011 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Neu isenburg : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Neu-Isenburg : 205.441.49001 Boehringer Ingelheim Investigational Site

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

Neu-Isenburg : 205.456.49007 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Neu-Isenburg : 205.445.49002 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Neu-Isenburg : 205.446.49002 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Oberhausen : 205.445.49013 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Oberhausen : 205.446.49013 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Potsdam : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Potsdam : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Rosenheim : 205.443.03008 Boehringer Ingelheim Investigational Site

Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

Rüdersdorf : Nycomed Investigational Site

Effect of High Dose Ciclesonide on Asthma Control

Ruedersdorf : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Ruedersdorf : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Ruedersdorf : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Schwetzingen : Nycomed Investigational Site

Effect of High Dose Ciclesonide on Asthma Control

Wesel : 205.456.49002 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Wiesbaden : 205.441.49002 Boehringer Ingelheim Investigational Site

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

Wiesbaden : Zentrum für Rhinologie und Allergie

Dose Finding Study Depigoid Phleum: 4 Doses in Patients With Allergic Rhinitis/Rhinoconjunctivitis +-Asthma

Wiesbaden : insaf - Respiratory Research Institute GmbH

Safety, Efficacy, PK, and PD Characteristics of Orally Inhaled SB010 in Male Patients With Mild Asthma (Multiple Dose)

Wiesloch : 205.441.49011 Boehringer Ingelheim Investigational Site

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

Wolfenbuettel : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Greece

Alimos : Vianex, S.A. / MSD Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Athens : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Heraklion/ Crete : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Thessaloniki : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Guatemala

Guatemala : MSD CARD Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Guatemala : 205.445.50201 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Guatemala City : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Guatemala City : 205.456.50201 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Guatemala City : 205.456.50203 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

View More »

Guatemala City : 205.456.50204 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Guatemala City : 205.456.50202 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Guatemala City : 205.456.50205 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Hungary

Ajka : 205.446.36002 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Balassagyarmat : Teva Investigational Site 36107

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Balassagyarmat : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Balassagyarmat : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Budapest : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

View More »

Budapest : MSD Pharma Hungary Kft. Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Budapest : Teva Investigational Site 36104

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Budapest : Teva Investigational Site 36105

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Budapest : 205.456.36005 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Budapest : 205.446.36001 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Cegled : 205.441.36003 Boehringer Ingelheim Investigational Site

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

Csoma : Teva Investigational Site 36514

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Csoma : Teva Investigational Site 36113

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Debrecen : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Debrecen : University of Debrecen Medical and Health Science Center

A Phase 3 Study to Compare Efficacy and Safety of Masitinib to Placebo in Treatment of Patients With Severe Persistent Asthma Treated With Oral Corticosteroids

Debrecen : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Debrecen : 205.456.36002 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Debrecen : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Deszk : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Deszk : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Godollo : 205.441.36002 Boehringer Ingelheim Investigational Site

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

Gyor : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Gyor : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Gyor : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Gyula : 205.456.36004 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Kiskunhalas : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Kiskunhalas : Illés és Ádám Egészségügyi Szolgáltató Bt.

Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients

Marcali : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Miskolc : Teva Investigational Site 36103

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Miskolc : 205.456.36001 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Mosdos : 205.456.36007 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Mosonmagyarovar : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Mosonmagyarovar : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Nagyatad : 205.456.36006 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Nagyatad : 205.446.36003 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Nyiregyhaza : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Nyiregyhaza : Teva Investigational Site 36102

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Nyiregyhaza : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Nyiregyhaza : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Pecs : 205.441.36001 Boehringer Ingelheim Investigational Site

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

Rakoczi : Vectura Clinical Trial Site 04005

Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma

Rakoczi : Vectura Clinical Trial Site 04002

Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma

Sopron : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Szazhalombatta : 205.441.36005 Boehringer Ingelheim Investigational Site

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

Százhalombatta : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Szeged : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Szeged : Teva Investigational Site 36506

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Szeged : Teva Investigational Site 36106

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Szeged : Teva Investigational Site 36109

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Szigetszentmiklos : 205.441.36004 Boehringer Ingelheim Investigational Site

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

Szigetvar : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Szikszo : Novartis Investigative Site

Safety and Efficacy of Mometasone Furoate Delivered Via Concept1 or Twisthaler® in Adult and Adolescent Patients With Persistent Asthma

Szombathely : Teva Investigational Site 36101

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Tatabanya : Teva Investigational Site 36111

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Tatabanya : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Torokbalint : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Torokbalint : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Torokbalint : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Veszprem : Teva Investigational Site 36512

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Zalaegerszeg : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

India

Ahmedabad : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Bangalore : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Bangalore : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Chennai : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Chennai : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

View More »

Coimbatore : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

GOA : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Hyderabaad : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Indore : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Indore : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Jaipur : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Ludhiana : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Mangalore : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Mangalore : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Mumbai : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Mysore : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Nagpur : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Nagpur : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Nagpur : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Nagpur - Maharashtra : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Panjim : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Panjim : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Pune : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Israel

Ashkelon : Teva Investigational Site 72511

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Ashkelon : Teva Investigational Site 72111

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Haifa : Teva Investigational Site 72101

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Haifa : Regional Pulmonary Clinic, Clalit Health Services

Diagnosis of Cardio-Pulmonary Pathology Using Transthoracic Parametric Doppler (TPD)

Holon : 205.456.97205 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

View More »

Jerusalem : Teva Investigational Site 72102

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Jerusalem : Teva Investigational Site 72104

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Kfar Saba : Teva Investigational Site 72109

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Petach Tikva : Teva Investigational Site 72106

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Petach Tikva : 205.456.97203 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Ramat-Gan : Teva Investigational Site 72107

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Rehovot : Teva Investigational Site 72103

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Tel Aviv : Teva Investigational Site 72110

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Zerifin : Teva Investigational Site 72105

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Italy

Benevento : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Bologna : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Catanzaro : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Cittadella PD : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Ferrara : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

View More »

Ferrara : Research Centre on Asthma and COPD, University of Ferrara

Small Airways Involvement in Smoker Asthmatic Patients: a Pilot Study

Firenze : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Firenze : Azienda Sanitaria Firenze Piero Palagi

International Cross-sectional and Longitudinal Assessment on Asthma Control (Liaison)

Foggia : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Genova : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Genova : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Genova : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Milan : MSD Italia

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Napoli : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Padova : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Palermo : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Parma : Dipartimento Cardio-Polmonare - Azienda Ospedaliero-Universitaria - Padiglione Rasori

A Study in Patients With Asthma

Parma : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Perugia : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Pietra Ligure (SV) : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Pisa : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Pisa : Cardio-Thoracic and Vascular Dept, University of Pisa

Efficacy and Safety of CHF 1535 200/6µg in Not Adequately Controlled Asthmatic Patients

Pisa : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Roma : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Japan

Aichi : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Akita : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Asahikawa : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Chiba : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Chiba : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

View More »

Chiba : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Chiyoda-ku : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Chuo-ku : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Chuo-ku : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Edogawa-ku : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Ehime : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Fukui : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Fukuoka : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Fukuoka : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Fukuoka : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Fukuoka : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Fukuoka-city : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Fukushima : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Gifu : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Gunma : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Gunma : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Hamamatsu : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Hatsukaichi-city : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Higashiibaraki-gun : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Himeji-city : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Hiroshima : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Hiroshima : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Hiroshima : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Hiroshima : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Hitachi : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Hokkaido : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Hokkaido : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Hokkaido : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Hyogo : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Hyogo : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Hyogo : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Ibaraki : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Ibaraki : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Ishikawa : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Itabashi : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Iwate : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Kagawa : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Kagawa : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Kagoshima : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Kanagawa : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Kanagawa : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Kanazawa : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Kasuga-city : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Kawasaki : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Kishiwada : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Kitakyushu : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Kiyose-city : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Kochi : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Kochi : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Koshigaya-city : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Kumamoto : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Kumamoto : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Kurashiki-city : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Kyoto : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Kyoto : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Mie : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Mie : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Minato-ku : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Miyagi : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Miyazaki : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Mizunami :

Pharmacological Effect of Lysozyme for Chronic Obstructive Pulmonary Disease and Asthma With Sputum Symptom

Nagano : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Nagasaki : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Nara : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Niigata : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Nishio-city : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Oita : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Okayama : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Okinawa : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Okinawa : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Osaka : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Osaka : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Osaka : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Saga : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Sagamihara-city : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Saitama : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Sakaide : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Sapporo : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Sapporo-city : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Setagaya-ku : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Shiga : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Shimane : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Shizuoka : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Tachikawa : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Tochigi : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Tokushima : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Tokyo : MSD K.K.

A Dose-Ranging Study of MK-1029 in Adults With Persistent Asthma (MK-1029-012 AM2)

Tokyo : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Tokyo : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Tokyo : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Toshima-ku : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Tottori : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Toyama : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Tsukubo-gun : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Wakayama : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Wakayama : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Yamagata : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Yamaguchi : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Yamanashi : Research Site

Clinical Experience Investigation of Symbicort Turbuhaler as Maintenance Therapy and Reliever Therapy

Yanagawa : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Yokohama-city : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Korea, Republic of

Ansan-si : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Anyang-Si : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Bucheon-si, : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Cheonan-si : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Cheongju : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

View More »

Cheongju, Chungcheongbuk-do : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Cheongju, Chungcheongbuk-do : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.

Cheongju, Chungcheongbuk-do : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Guri : 205.445.82003 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Guri-si : 205.443.82003 Boehringer Ingelheim Investigational Site

Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

Gwangju : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Ilsanseo-gu, Goyang-si, Gyeonggi-do : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.

Incheon : 205.445.82002 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Incheon : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Incheon : 205.443.82002 Boehringer Ingelheim Investigational Site

Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

jeonju-si, Jeollabuk-Do : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Jinju-si : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Kangwon-do : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Seongnam-si : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Seongnam-si, Gyeonggi-do : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry

Seongnam-si, Gyeonggi-do : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.

Seoul : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Seoul : Seoul National University Hospital

Dose Finding Trial to Assess the Efficacy and Safety of SOTB07 in Persistent Asthma

Seoul : 205.445.82004 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Seoul : 205.445.82001 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Seoul : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Seoul : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry

Seoul : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.

Seoul : 205.443.82004 Boehringer Ingelheim Investigational Site

Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

Seoul : Seoul St. Mary's Hospital of the Catholic university of Korea

Safety and Efficacy of SA09012 in Asthma

Seoul : Yuhan Corporation

Safety and Efficacy of YHD001 in Asthma

Seoul : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Seoul : Novartis Investigative SIte

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Seoul : Samsung medical center

Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients

Seoul : Seoul National University

Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients

Seoul : Asan Medical Center

Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients

Seoul : Hanyang University Hospital

Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients

Seoul, : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry

Suwon : Ajou University Medical Center

Asthma Control in Elderly Patients With Montelukast

Suwon : Ajou University Hospital

Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients

Suwon, Kyonggi-do : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Suwon, Kyonggi-do : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Latvia

Adazi : 205.445.37104 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Baldone : 205.456.37101 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Baldone : 205.445.37101 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Baldone : 205.446.37105 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Balvi : 205.456.37104 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

View More »

Balvi : 205.445.37106 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Balvi : 205.446.37104 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Balvi : 205.443.05001 Boehringer Ingelheim Investigational Site

Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

Daugavpils : 205.446.37108 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Jekabpils : 205.446.37107 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Ogre : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Ogre : 205.445.37102 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Ogre : 205.446.37101 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Rezekne : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Rezekne : 205.456.37103 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Rezekne : 205.445.37107 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Rezekne : 205.446.37106 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Rezekne : 205.443.05003 Boehringer Ingelheim Investigational Site

Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

Riga : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Riga : Merck Sharp & Dohme Latvija SIA Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Riga : 205.456.37102 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Riga : 205.445.37103 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Riga : 205.445.37105 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Riga : 205.446.37102 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Riga : 205.446.37103 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Severe Persistent Asthma

Riga : 205.443.05002 Boehringer Ingelheim Investigational Site

Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

Talsi : 205.456.37105 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Malaysia

Kelantan : 205.443.10002 Boehringer Ingelheim Investigational Site

Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

Kuala Lumpur : 205.443.10001 Boehringer Ingelheim Investigational Site

Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

Mexico

Durango : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Guadalajara : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Guadalajara : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Hermosillo Sonora : 205.456.52001 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Mexicali : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

View More »

Mexico : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

México : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Mexico City : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Monterrey : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Monterrey : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Monterrey : 205.456.52002 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Monterrey : 205.456.52003 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Morelia : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Morelia : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma

Nuevo León : 205.456.52004 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Puebla, Pue : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Villahermosa : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Villahermosa : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma

Villahermosa : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Zapopan : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Zapopan : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Zapopan : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma

Zapopan : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Zapopan : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Netherlands

Almelo : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Almelo : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Amsterdam : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Amsterdam : Academic Medical Center

Mepolizumab Treatment for Rhinovirus-induced Asthma Exacerbations

Eindhoven : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

View More »

Eindhoven : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Groningen : University Medical Center Groningen Updated

Determining the Optimal Adenosine Provocation Test

Groningen : University Medical Center Groningen

Development of Small Airway Disease Questionnaire

Groningen : 205.443.04001 Boehringer Ingelheim Investigational Site

Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

Harderwijk : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Hoogwoud : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Hoorn : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Leeuwarden : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Rotterdam : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Zutphen : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Zutphen : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

New Zealand

Auckland :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Dunedin :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Hamilton :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Wellington :

A Study of MEMP1972A in Patients With Allergic Asthma Inadequately Controlled on Inhaled Steroids And A Second Controller (COSTA)

Norway

Bergen : 205.456.47001 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Pakistan

Vehari : District Headquarters Hospital

Evaluation of Essential Surgical Skills-Emergency Maternal and Child Health (ESS-EMCH) Training by Assessing the Doctors' Practices

Panama

Ciudad de Panama : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Peru

Cercado de Lima : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Jesus Maria : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Lima : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Lima : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Lima : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma

View More »

Lima : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Lima : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Lima 18 : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma

Lima 27 : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Miraflores : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

San Borja : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma

San Borja : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

San Isidro : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

San Miguel : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

San Miguel : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma

Santiago de Surco : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Santiago de Surco : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Philippines

Cebu City : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Lipa City : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry

Manila : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Manila : 205.456.09001 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Marilao, Bulacan : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.

View More »

Quezon City : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Quezon City : 205.456.09002 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Quezon City : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry

Quezon City : GSK Investigational Site

Evaluating the Efficacy and Safety of Fluticasone Furoate/Vilanterol Trifenatate in the Treatment of Asthma in Adolescent and Adult Subjects of Asian Ancestry.

Quezon City : 205.443.09002 Boehringer Ingelheim Investigational Site

Evaluation of Tiotropium 2.5 and 5 Mcg Once Daily Delivered Via the Respimat® Inhaler Compared to Placebo in 1 to 5 Year Old Patients With Persistent Asthma

Poland

Bialystok : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Bialystok : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Bialystok : Vectura Clinical Trial Site 05010

Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma

Bialystok : Vectura Clinical Trial Site 05002

Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma

Bialystok : Vectura Clinical Trial Site 05008

Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma

View More »

Bialystok : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Bydgoszcz : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Bydgoszcz : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Checiny : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Czestochowa : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Debica : Poradnia Alergologiczna

Bronchodilator Effect of CHF1535 pMDI Versus Free Combination of Beclometasone Plus Formoterol pMDI in Asthmatic Children

Gorzow Wlkp : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Karpacz : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Katowice : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Krakow : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Krakow : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Krakow : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Krakow : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Krakow : Vectura Clinical Trial Site 05011

Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma

Krakow : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Krakow : GSK Investigational Site

Mepolizumab Steroid-Sparing Study in Subjects With Severe Refractory Asthma

Lodz : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Lodz : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Lodz : Vectura Clinical Trial Site 05006

Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma

Lublin : Teva Investigational Site 48513

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Lublin : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Lublin : Vectura Clinical Trial Site 05005

Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma

Lublin : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Olesnica : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Ostrow Wielkopolski : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Pabianice : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Poznan : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Skarzysko Kamienna : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Strzelce Opolskie : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Szczecin : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Tarnow : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Tarnow : Teva Investigational Site 48503

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Tarnow : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Tarnow : Vectura Clinical Trial Site 05007

Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma

Tarnow : Alergo-Med Specjalistyczna Przychodnia Lekarska Sp.z.o.o.

Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients

Turek : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Urszulin : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Warszawa : MSD Polska Sp. Z o.o. Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Wroclaw : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Wroclaw : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Wroclaw : Vectura Clinical Trial Site 05009

Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma

Wroclaw : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Zawadzkie : Vectura Clinical Trial Site 05004

Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma

Zawadzkie : GSK Investigational Site

Dose-ranging Study of Vilanterol (VI) Inhalation Powder in Children

Portugal

Aveiro : 205.445.35106 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Coimbra : 205.456.35105 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Lisboa : 205.456.35101 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Lisboa : 205.456.35104 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Lisboa : 205.456.35102 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

View More »

Lisboa : 205.445.35101 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Lisboa : 205.445.35102 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Porto : 205.456.35103 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Porto : 205.445.35103 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Porto : 205.445.35105 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat® Compared to Placebo in Children With Moderate Persistent Asthma

Puerto Rico

Carolina : Merck Sharp & Dohme (I.A.) Corp. Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Toa Baja : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Qatar

Doha : Hamad Medical Corporation

Blood Collection From Individuals With Lung Disease for Genetic Studies (Qatar)

Doha : Hamad Medical Corporation- Pediatriv Emergency Center

Correction of Vitamin D in Asthma Control

Romania

Arad : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Bacau : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Brasov : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Brasov : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Bucharest : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

View More »

Bucharest : Merck Sharp & Dohme Romania SRL Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)

Bucharest : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Bucharest : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Bucharest : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Bucharest : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Bucharest : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Bucuresti :

A Non-drug Study Profiling Asthma

Bucuresti : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Bucuresti : Vectura Clinical Trial Site 07005

Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma

Bucuresti : Vectura Clinical Trial Site 07008

Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma

Bucuresti : Vectura Clinical Trial Site 07013

Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma

Cluj Napoca : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Constanta : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Craiova : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Craiova : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Craiova : Vectura Clinical Trial Site 07014

Clinical Study to Evaluate the Efficacy and Safety of VR506 Using a New Inhaler for the Treatment of Asthma

Deva : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Deva : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Deva : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Deva, Hunedoara : Spitalul Judetean de Urgenta Deva

Comparison of Flutiform, Fluticasone and Seretide in Treatment of Moderate to Severe Asthma in Paediatric Patients

Iasi : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Iasi : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Iasi : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Iasi : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Ploiesti : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Targu Mures : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Tg. Mures : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Timisoara : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Timisoara : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Russian Federation

Barnaul : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Barnaul : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

Barnaul : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Blagoveshchensk : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Chelyabinsk : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

View More »

Chelyabinsk : GSK Investigational Site

MEA112997 Open-label Long Term Extension Safety Study of Mepolizumab in Asthmatic Subjects

Chita : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Ekaterinburg : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Ekaterinburg : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Ekaterinburg : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Ivanovo : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Kazan : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Kazan : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Kazan : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

Kemerovo : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Klin : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma

Klin : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

Moscow : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Moscow : Teva Investigational Site 70512

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Moscow : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Moscow : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Moscow : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma

Moscow : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Moscow : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

Novosibirsk : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Novosibirsk : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

Pyatigorsk : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Ryazan : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Ryazan : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Saint-petersburg : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Saint-Petersburg : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

St. Petersburg : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

St. Petersburg : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate and Fluticasone Propionate in People With Asthma

St. Petersburg : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma

St. Petersburg : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

St. Petersburg : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

St. Petersburg : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

St.-Petersburg : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Stavropol : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

St-petersburg : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Tomsk : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Tomsk : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

Ufa : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

Vladikavkaz : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Vladivostok : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Volgograd : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Voronezh : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma

Yaroslavl : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Yaroslavl : GSK Investigational Site

Clinical Study Evaluating Safety and Efficacy of Fluticasone Furoate in People With Asthma

Yaroslavl : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Yaroslavl : GSK Investigational Site

Evaluate the Safety, Efficacy and Dose Response of GSK573719 in Combination With Fluticasone Furoate in Subjects With Asthma

Yekaterinburg : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Slovakia

Banska Bystrica : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Bardejov : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Bardejov : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Bojnice : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Bratislava : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

View More »

Bratislava : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Dunajska Streda : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Komarno : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Kosice : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Kosice : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Levice : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Liptovsky Hradok : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Liptovsky Mikulas : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Michalovce : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Nitra : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Nitra : Novartis Investigative Site

Efficacy and Safety of QGE031versus Placebo and Omalizumab in Patients Aged 18-75 Years With Asthma

Nitra : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Presov : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Ruzomberok : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Surany : Novartis Investigative Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Trencin : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Vrable : Novartis Investigator Site

Safety of QMF149 Twisthaler® in Adolescent and Adult Patients With Asthma

Zilina : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Zvolen : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Slovenia

Golnik : 205.441.38601 Boehringer Ingelheim Investigational Site

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

Kamnik : 205.441.38602 Boehringer Ingelheim Investigational Site

Comparison of Two Daily Dose Regimens of Tiotropium 5 µg Once Daily and Tiotropium 2.5 µg Twice Daily for 4 Weeks on Top of Maintenance Therapy With Inhaled Corticosteroid Controller Medication

South Africa

Amanzimtoti : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Benoni : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Boksburg North : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Breyton : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Cape Town : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

View More »

Cape Town : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Cape Town : 205.456.27001 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Durban : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Durban : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Durban : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Durban : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Durban : 205.456.27002 Boehringer Ingelheim Investigational Site

Efficacy and Safety of 2 Doses of Tiotropium Respimat Compared to Placebo in Adolescents With Severe Persistent Asthma

Gatesville : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Krugersdorp : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Lenasia : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Lenasia : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Panorama : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Pietermariztburg : Research Site

A 6-week Study in Asthmatic Children Aged 6 to <12 Yrs Comparing Budesonide pMDI 160ug Twice Daily With Placebo

Port Elizabeth : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Pretoria : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Pretoria : Novartis Investigative Site

Dose Finding Study for QAW039 in Asthma

Umkomaas : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Verulam : Research Site

A 6 Month Safety Study Comparing Symbicort With Inhaled Corticosteroid Only in Asthmatic Adults and Adolescents

Spain

Alicante : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Aranjuez : Teva Investigational Site 34507

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Barcelona : Teva Investigational Site 34102

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Barcelona : GSK Investigational Site

Efficacy and Safety Study of Mepolizumab Adjunctive Therapy in Subjects With Severe Uncontrolled Refractory Asthma

Guadalajara : Hospital Universitario de Guadalajara

Impact of Adherence to Treatment in Asthma Control

View More »

Lleida : Teva Investigational Site 34506

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Madrid : Teva Investigational Site 34505

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler (Puffer) in Adolescents and Adults Who Have Asthma That is Not Controlled by High Dose Inhaled Corticosteroid Asthma Medications

Manresa : H. Manresa

Safety Clinical Trial With Depigopid 50% Grasses/50% Olea Europaea(2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria Judaica(2000DPP/ml).

Salt : Teva Investigational Site 34103

A Study of the Effectiveness and Safety of Different Doses of Fluticasone Propionate Taken From a Dry Powder Inhaler in Adolescents and Adults Who Have Asthma That is Not Controlled by Asthma Medications Not Containing Steroids

Sevilla : H. Virgen Macarena

Safety Clinical Trial With Depigopid 50% Grasses/50% Olea Europaea(2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria Judaica(2000DPP/ml).

Sevilla : H. Virgen del Rocío

Safety Clinical Trial With Depigopid 50% Grasses/50% Olea Europaea(2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria Judaica(2000DPP/ml).

Xativa : H. Luis Alcañiz

Safety Clinical Trial With Depigopid 50% Grasses/50% Olea Europaea(2000DPP/ml) or Depigoid 50% Grasses/50% Parietaria Judaica(2000DPP/ml).

Sweden

Göteborg : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Luleå : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Lund : GSK Investigational Site

An Efficacy and Safety Study of Fluticasone Furoate/Vilanterol (FF/VI) 200/25 Microgram (Mcg) , FF/VI 100/25 Mcg, and FF 100 Mcg in Adults and Adolescents With Persistent Asthma.

Uppsala : Lungkliniken, Universitetssjukhuset i Uppsala

Optimization of Inhaled Corticosteroid Treatment in Adult Patients With Asthma Guided by Exhaled NO Measurement at Home

Switzerland

Glattbrugg : MSD Merck Sharp & Dohme AG Updated

A Study of Mometasone Furoate Metered Dose Inhaler in Children With Persistent Asthma (P04223 AM2)